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neurovascular	 diseases.	 These	 diseases	 pose	 a	 high	 burden	 on	 our	 society,	 both	 in	
terms	 of	 suffering	 as	well	 as	 financially.	 From	 a	 perspective	 of	 disease	 prevention,	
the	 search	 for	potentially	modifiable	 etiologic	 factors	 and	a	better	understanding	of	
the	pathophysiological	pathways	of	age-related	brain	diseases	is	of	major	importance.	
One	 approach	 in	 this	 is	 to	 study	 brain	 disease	 in	 its	 earliest	 stage,	 before	 clinical	
symptoms	arise.	Subclinical	brain	changes	are	thought	to	occur	years,	if	not	decades,	
prior	to	onset	of	clinical	symptoms	of	many	age-related	diseases1,	and	with	advanced,	
non-invasive	 imaging	methods	we	are	able	 to	 study	 these	 subclinical	brain	changes	
directly.	In	the	past,	research	has	mainly	focused	on	cerebral	grey	matter	in	age-related	








occurred.3	To	 improve	 understanding	 of	 the	 pathophysiology	 and	 pathways	 of	 age-
related	brain	 diseases	 it	 is	 important	 to	 identify	white	matter	 pathology	 in	 an	 early	
and	preclinical	phase.	More	recently,	microstructural	white	matter	changes,	not	visible	









Imaging	 data	 of	 white	matter	 microstructural	 changes	 from	 the	 general	 population	
might	help	to	disambiguate	between	normal	and	abnormal,	help	to	understand	underly-
ing	mechanisms	of	pathology	and	may	help	 to	 identify	persons	at	 risk	 for	a	certain	
disease.	However,	 population	 data	 on	 determinants	 of	white	matter	microstructural	




AIM of thIS theSIS
The	 objectives	 of	 this	 thesis	were	 two-fold:	 Firstly,	 to	 study	 determinants	 of	white	
matter	microstructural	changes.	The	brain	 is	not	an	organ	on	 itself	but	 is	connected	
with	all	other	organs	in	our	body	and	therefore	we	are	in	particular	interested	in	the	
systemic	influences	on	the	brain	of	different	organs.	Secondly,	to	investigate	the	link	
between	white	matter	microstructural	 and	 age-related	 brain	 diseases.	 In	 both	 aims,	
I	 focused	both	on	 the	white	matter	microstructural	 changes	 across	 the	whole	brain,	






outLINe of thIS theSIS
Chapter 2	discusses	determinants	of	white	matter	microstructural	damage.	In	chapter 
2.1	 I	describe	the	change	in	DTI-measures	in	aging.	In	chapter 2.2 and 2.3	 I	focus	
on	the	association	between	kidney	function	and	white	matter	microstructural	integrity	





but	also	 in	 specific	 tracts	with	different	age-related	brain	diseases.	 In	chapter 3.1	 I	
focus	on	a	transitional	stage	between	normal	aging	and	dementia,	namely	mild	cogni-
tive	 impairment	 and	 studied	 the	 determinants,	MRI	markers	 and	 prognosis	 of	mild	
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ment	 approved	 this	 prospective,	 population-based	 cohort	 study	 and	 all	 participants	


























magnetic	 resonance	 imaging	 (MRI)	 technique	 that	measures	diffusion	of	water,	 and	









it	 is	 important	 to	 quantify	 changes	 in	 brain	 tissue	 in	 an	 early	 stage.5	This	 however	
also	 requires	 characterization	 of	 baseline	 age-related	 changes.	 The	 quantitative	 na-
ture	makes	DTI	very	suitable	for	 longitudinal	analyses,	which	are	 likely	to	be	more	
sensitive	in	the	early	detection	of	changes	in	white	matter	microstructure.	However,	














This	 study	 is	 based	 on	 participants	 from	 the	 Rotterdam	 Study,	 a	 prospective,	 pop-






to	participate	 in	 the	Rotterdam	Scan	Study.17	Participants	were	scanned	 three	 times,	
in	2005-2006,	2008-2009	and	 in	2011-2012.	The	 latter	 two	 time	points	 included	an	
upgraded	DTI	acquisition	 that	was	used	 for	 the	current	analysis,	defining	 the	2008-
2009	scan	as	baseline,	and	the	2011-2012	scan	as	follow-up.	We	excluded	individuals	




participants	with	 an	 incomplete	 acquisition	 (n=5),	 persons	with	MRI-defined	 corti-
cal	infarcts	(n=20),	and	scans	with	artifacts	hampering	automated	processing	(n=22),	





Multi-sequence	MRI	was	 performed	with	 identical	 scan	 parameter	 settings	 at	 both	
time	 points	 on	 a	 1.5T	 scanner	 (GE	Signa	Excite)	 dedicated	 to	 the	 study	 and	main-
tained	 without	 major	 hardware	 or	 software	 updates.17 In	 short,	 imaging	 included	 a	
T1-weighted	3D	Fast	RF	Spoiled	Gradient	Recalled	Acquisition	in	Steady	State	with	
an	 inversion	 recovery	 pre-pulse	 (FASTSPGR-IR)	 sequence,	 a	 proton	 density	 (PD)	
weighted	sequence,	and	a	T2-weighted	fluid-attenuated	 inversion	 recovery	 (FLAIR)	
sequence.17	 For	 DTI,	 we	 performed	 a	 single	 shot,	 diffusion-weighted	 spin	 echo	
echo-planar	 imaging	 sequence	 (repetition	 time=8575	ms,	 echo	 time=82.6	ms,	field-




















Marquardt	 estimator,	 available	 in	 ExploreDTI.22	 FA	 and	 MD,	 measures	 of	 tissue	
microstructure,	were	computed	from	the	tensor	images.	Tensor	fits	were	inspected	for	




Intra-subject	 correspondence	 (between	 the	 two	 time	 points),	 and	 correspondence	
between	 subjects	 was	 achieved	 by	 image	 registration.	 Improved	 tract-based	 spatial	
statistics	(TBSS)	was	used	with	optimized	high	degree-of-freedom	registration	in	lieu	









Assessment of risk factors
The	following	cardiovascular	risk	factors	were	assessed	based	on	information	derived	








high-density	 lipoprotein	 (HDL)	 cholesterol	were	 determined	 in	 blood	 serum,	while	























for	 the	 same	models	 as	 for	 the	 global	 analysis,	 also	 restricting	 the	 analyses	 to	 the	
(baseline)	normal-appearing	white	matter.	 If	 significant	 associations	were	 found	 for	
tests	 in	model	 3,	we	 additionally	 performed	 an	 analysis	 correcting	 for	measures	 of	









table 1	 shows	 the	 population	 characteristics	 of	 the	 501	 participants.	Mean	 age	 at	








































the	 two-years	 follow-up	 interval	 in	 the	 majority	 of	 the	 brain	 white	 matter,	 except	






MD	mostly	 increased.	Constraining	 the	voxelwise	 analysis	 to	 the	normal-appearing	




variable change in fA
(x 10-3)
p value change in Md
(x 10-6mm2/s)
p value
Age -0.12 0.09 0.20 0.01
Sex 0.37 0.57 -0.07 0.93
Brain	volume -0.18 0.69 0.91 0.08
NAWM	volume 0.27 0.51 -1.43 2	x	10-3
ln(WML	volume) -0.29 0.31 1.21 2	x	10-4
                                    White	matter	degeneration	with aging 
26 
changes.	The	top	row	shows	regions	of	significant	change	in	fractional	anisotropy	
(FA)	 over	 time,	 color	 coded	 blue	 to	 indicate	 increase,	 and	 red	 and	 yellow	 to	
indicate	 decrease	 in	FA.	The	 bottom	 row	 shows	 regions	 of	 significant	 change	 in	
mean	 diffusivity	 (MD),	 color-coded	 blue	 for increase	 (no	 voxels	 showed	 a	
significant	decrease	in	MD).	Results	shown	are	p<0.05,	the	family	wise	error	rate	















figures 2 and 3	show	how	changes	in	FA	(figure 2)	and	MD	(figure 3)	depended	on	
various	parameters	included	in	models	1	and	2.	For	model	1,	we	observed	associations	






                                    White	matter	degeneration	with aging 
27 
figure 2. Age	and	macrostructural	white	matter	changes	at	baseline	and	change	in	
fractional	 anisotropy	 (FA)	 over	 two-years	 of	 follow-up.	 The	 top	 row	 shows	 in	
yellow-to-red	 regions	 of	 decrease	 in	 FA	 that	 relate	 to	 higher	 age	 at	 baseline	
(adjusted	 for	 sex,	 scan	 interval	 and	 intracranial	 volume	 (ICV)).	 The	 second	 and	
third	 row	 show	 FA	 changes	 that	 are	 associated	 with	 respectively	 a	 decrease	 in	
normal-appearing	white	matter	(NAWM)	volume	and	an	increase	in	white	matter	
lesion	 (WML)	volume	 (both	 adjusted	 for	age,	 sex,	 scan	 interval,	 ICV).	The	 final	
row	 shows	 regions	 of	 decrease	 in	 FA	 related	 to	 higher	 age,	 when	 additionally	
adjusted	for	NAWM	volume	and	WML	volume.	 Inverse	directions	of	association	
showed	no	 significant	 voxels	 (not	 shown).	Results	 shown	 are	p<0.05,	 the	 family	
wise	error	rate	was	controlled	using	a	permutation	approach.	P values	are	presented	
in	Supplementary	Figure	3.	Results	are	overlaid	on	a	population	specific	average-























in	 a	 small	 peritrigonal	 cluster	 in	 carriers	 compared	 to	 non-carriers.	These	 observed	
associations	 persisted	when	 additionally	 correcting	 for	macrostructural	measures	 of	




                                    White	matter	degeneration	with aging 
28 
figure 3. Age	and	macrostructural	white	matter	changes	at	baseline	and	change	in	
mean	 diffusivity	 (MD)	 over	 two-years	 of	 follow-up.	 The	 top	 row	 shows	 in	 blue	
regions	of	 increase	 in	MD	 that	 relate	 to	higher	 age	 at	 baseline	 (adjusted	 for	 sex,	
scan	interval	and	intracranial	volume	(ICV)).	The	second	and	third	row	show	MD	
changes	that	are	associated	with	respectively	a	decrease	in	normal-appearing	white	
matter	 (NAWM)	 volume	 and	 an	 increase	 in	white	matter	 lesion	 (WML)	 volume	
(both	 adjusted	 for	 age,	 sex,	 scan	 interval,	 ICV).	The	 final	 row	 shows	 regions	 of	
decrease	 in	 MD	 related	 to	 higher	 age,	 when	 additionally	 adjusted	 for	 NAWM	
volume	and	WML	volume.	Inverse	directions	of	association	showed	no	significant	































in	 a	 small	 peritrigonal	 cluster	 in	 carriers	 compared	 to	 non-carriers.	These	 observed	
associations	 persisted	when	 additionally	 correcting	 for	macrostructural	measures	 of	
white	matter	 degeneration.	 Similarly,	we	 observed	 that	 global	 increase	 in	MD	 to	 a	
lesser	degree	associated	with	APOE ε4	carriership	(table 3).
Total	 serum	 cholesterol	 level	 was	 associated	 locally	 with	 more	 increase	 in	MD	 in	
the	 left	 hemisphere.	 Regions	 included	 the	 corona	 radiata	 and	 white	 matter	 around	
the	posterior	and	anterior	horns	of	 the	lateral	ventricle.	These	observed	associations	
persisted	when	additionally	correcting	for	macrostructural	measures	of	white	matter	




risk / protective factor change in fA
(x 10-3)
p value change in Md
(x 10-6mm2/s)
p value
Systolic	blood	pressure	 -0.46 0.09 0.33 0.29
Diastolic	blood	pressure	 -0.01 0.98 0.10 0.76
Diabetes	mellitus 0.08 0.77 0.46 0.13
Smoking	(never	-	current) -0.15 0.86 0.22 0.83
Total	serum	cholesterol	 -0.42 0.15 -0.09 0.78
Serum	HDL	cholesterol	 0.31 0.28 -0.23 0.49
APOE-ε4	carriership 1.12 0.07 -1.51 0.04
Cardiovascular	 risk	 factors	and	global	change	 in	white	matter	microstructure	computed	with	 respect	 to	 the	






In	 this	 large,	 population-based	 longitudinal	 sample	 of	 elderly	 persons,	 we	 found	
changes	 to	microstructural	 tissue	organization	congruent	with	microstructural	white	



















of	white	matter	degeneration.10	Both	 results	 indicate	 that	white	matter	degeneration	





In	 the	sensorimotor	pathway,	we	 identified	a	seemingly	paradoxical	 increase	of	FA,	



















ies	with	APOE	 genotype,	which	 have	 generally	 shown	widespread	 deterioration	 of	
white	matter	microstructure	associated	with	the	ε4	allele.33,34	On	closer	inspection	this	
paradoxical	 increase	 in	FA	was	 largely	explained	by	 lower	baseline	FA	for	carriers,	
and	 a	 larger	 decrease	 in	 FA	 for	 non-carriers.	Higher	 serum	 cholesterol	was	 associ-
ated	to	stronger	increases	in	MD	over	time	in	the	left	hemisphere.	When	investigating	
other	 cardiovascular	 risk	 factors,	 we	 observed	 associations	with	 neither	 global	 nor	
local	changes	to	white	matter	microstructure,	which	is	in	line	with	another	longitudinal	
study6	 but	 in	 disagreement	 to	 cross-sectional	 observations.2,35	 These	 discrepancies,	
both	for	APOE	and	cardiovascular	factors,	might	be	due	to	the	relatively	short	follow-





over	 the	 total	 exposure	 time,	which	 precludes	 the	 analysis	 from	finding	 subtle	 dif-
ferential	changes	with	cardiovascular	risk	factors.		
Limitations	 of	 our	 study	 are:	 1.	The	 relatively	 short	 follow-up	 interval,	which	may	
have	limited	the	sensitivity	to	detect	differences	over	time.	Especially	in	the	case	of	
differential	 effects	with	 risk	 factors	 (as	mentioned	 above),	 this	meant	we	 could	 not	




standards.23	Although	 the	use	of	TBSS	mitigates	partial	volume	effects	 in	 the	major	
white	matter	 tracts	 and	we	 adjusted	 for	 overall	white	matter	 atrophy,	we	will	 have	
been	less	sensitive	to	detect	change	in	very	thin	tracts.	We	did	nevertheless	identify	









in	 normal	 aging,	we	 found	widespread	microstructural	 deterioration	 of	 the	 normal-
appearing	white	matter,	with	relative	sparing	of	sensorimotor	fibers.	We	found	changes	
to	be	more	prominent	in	older	persons,	which	were	partly	explained	by	concomitant	
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Methods	 We	 included	 2726	 participants	 with	 a	 mean	 age	 of	 56.6	 years	 (45%	
men)	 from	 the	 population-based	Rotterdam	Study.	Albumin-to-creatinine	 ratio,	 and	
glomerular	filtration	 rate	 (eGFR),	using	 serum	cystatin	C	 (eGFRcys)	 and	creatinine	
(eGFRcr),	 were	measured	 to	 evaluate	 kidney	 function.	 Diffusion-MRI	was	 used	 to	
assess	microstructural	integrity	of	the	normal-appearing	white	matter.	Multiple	linear	





eGFRcys	 was	 associated	 with	 worse	 global	 white	 matter	 microstructural	 integrity,	
reflected	as	lower	fractional	anisotropy	(FA)	(standardized	difference	per	SD:	-0.053,	
95%CI:	 -0.092,	 -0.014)	 and	 higher	 mean	 diffusivity	 (MD)	 (0.036,	 95%CI:	 0.001,	
0.070).	 Similarly,	 higher	 albumin-to-creatinine	 ratio	 was	 associated	 with	 lower	 FA	
(-0.044,	95%CI:	-0.078,	-0.011).	There	was	no	linear	association	between	eGFRcr	and	
white	matter	integrity.	Subgroup	analyses	showed	attenuation	of	the	associations	after	




structural	 integrity.	Our	findings	 highlight	 the	 importance	 for	 clinicians	 to	 consider	










evident	 cerebrovascular	 diseases,	 previous	 studies	 showed	 an	 association	 between	
kidney	function	and	subclinical	cerebrovascular	diseases	including	brain	atrophy	and	
white	matter	lesions.2,	4,	5	However,	subclinical	cerebrovascular	diseases	have	a	wide	






function	are	associated	with	brain	pathologies,2,	3	 it	 is	unknown	whether	changes	 in	
kidney	 function	 and	 glomerular	 integrity	 are	 linked	 to	more	 subtle,	microstructural	









Standard Protocol Approvals, registrations, and Patient Consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	












(further	 details	 about	 kidney	 function	measurements	 in	 supplemental	material).	We	

























matter	 tract,	with	 subsequent	 combination	of	 left	 and	 right	measures.14	DTI	values,	
both	global	and	tract-specific,	were	measured	using	fully	automated	methods	(no	read-
ers	involved).	Since	these	measures	are	not	observer	dependent,	no	observer	bias	was	









Smoking	 was	 categorized	 in	 never,	 former	 and	 current	 smoking.	 Information	 on	
medication	use	was	based	on	home	interviews.	Hypertension	was	defined	as	a	systolic	
blood	pressure	≥140	mmHg	or	a	diastolic	blood	pressure	≥	90	mmHg	or	 the	use	of	
antihypertensive	medication.	Cardiovascular	 disease	was	 considered	 as	 a	 history	 of	
myocardial	 infarction,	 stroke	 or	 coronary	 revascularization	 procedures.16	 Diabetes	




















term	 in	 the	model.	We	 performed	 an	 analysis	 of	 covariance	where	mean	 values	 of	



































vascular	 risk	 factors,	 in	 the	 third	model,	 associations	 of	 albumin-to-creatinine	 ratio	






















































eGfr<60 and ACr >30
N=14
Age,	years 56.4	(5.9) 60.5	(9.6) 65.4	(9.2)
Men 1040	(44.8) 76	(42.5) 7	(50.0)
SBP,	mmHg 131.4	(18.1) 139.6	(21.1) 145.5	(23.5)
DBP,	mmHg 82.1	(10.7) 85.1	(12.0) 85.1	(11.2)
Anti-HTN	Med 476	(20.5) 68	(38.0) 11	(78.6)
Alcohol
			Moderate	drinker 1393	(60.0) 111	(62.0) 6	(42.9)
			Heavy	drinker 694	(29.0) 45	(25.1) 4	(28.6)
Smoking
			Current 590	(25.4) 49	(27.4) 4	(28.6	)
			Former 1014	(43.7) 80	(44.7) 7	(50.0)
Total	chol,	mmol/l 5.6	(1.0) 5.4	(1.1) 5.8	(1.3)
HDL	chol,	mmol/l 1.4	(0.4) 1.3	(0.4) 1.4	(0.5)
Lipid	lowering	Med 469	(20.2) 53	(29.6) 6	(42.9)
DM 155	(6.7) 34	(19.0) 2	(14.3)
CVD 99	(4.3) 19	(10.6) 2	(14.3)
HTN 982	(42.3) 116	(64.8) 14	(100)
BMI,	kg/m2 27.4	(4.2) 29.0	(5.1) 28.4	(4.6)
ACR,	mg/g 3.3	(2.1,	5.5) 39.0	(8.4,	74.4) 130.1	(73.4,	229.1)
eGFRcr,	mL/min/1.73	m2 87.0	(11.9) 77.3	(18.9) 44.8	(16.7)
eGFRcys,	mL/min/1.73	m2 87.4	(14.3) 74.2	(21.4) 38.1	(13.3)
eGFRcrcys,	mL/min/1.73	m2 87.4	(11.7) 75.6	(20.0) 40.2	(13.9)
ICV,	mL 1127.6	(121.1) 1125.3	(136.9) 1103.7	(133.5)
WMV,	mL 417.3	(58.7) 408.7	(68.5) 385.9	(93.1)
WMLV,	mL 2.0	(1.3,	3.4) 2.9	(1.6,	5.5) 8.9	(3.1,	13.0)
FA 0.33	(0.01) 0.33(0.01) 0.32	(0.02)
MD,	10-3 mm2/s 0.74	(0.02) 0.75	(0.03) 0.76	(0.03)
Axial	diffusivity,	10-3 mm2/s 1.01	(0.03) 1.02	(0.03) 1.03	(0.03)




Abbreviations: SBP: systolic blood pressure, DBP: diastolic blood pressure, Anti-HTN Med: antihypertensive 
medication, Total chol: total cholesterol, HDL chol: high density lipoprotein cholesterol, DM: diabetes mel-
litus, CVD: cardiovascular disease, HTN: hypertension, BMI: body mass index, ACR: Albumin-to-creatinine 
ratio, eGFRcys: cystatin C based estimated glomerular filtration rate, eGFRcr: creatinine based estimated 
glomerular filtration rate, eGFRcrcys: creatinine and cystatin C based estimated glomerular filtration rate, 
ICV: intracranial volume, WMV: white matter volume, WMLV: white matter lesion volume. FA: fractional 






radial	 diffusivity	 (-0.268,	 95%CI:	 -0.303,	 -0.233)	 and	 lower	 axial	 diffusivity	 (-0.157,	
95%CI:	-0.194,	-0.120).	The	association	of	eGFRcys	with	FA,	MD,	and	radial	diffusiv-










fractional anisotropy Mean diffusivity Axial diffusivity Radial diffusivity
Difference*(95% CI) Difference*(95% CI) Difference*(95% CI) Difference*(95% CI)
Albumin-to-creatinine ratio N= 2680
			Model	I -0.102 (-0.139, -0.066) 0.096 (0.061, 0.132) 0.063 (0.027, 0.100) 0.103 (0.067, 0.139)
			Model	II -0.049 (-0.081, -0.016) 0.033(0.004, 0.062) 0.018	(-0.015,	0.050) 0.037 (0.008, 0.066)
			Model	III -0.044 (-0.078, -0.011) 0.026(-0.004,	0.056) 0.010	(-0.024,	0.044) 0.031 (0.001, 0.061)
			Model	IV -0.043 (-0.078, -0.008) 0.027	(-0.004,	0.058) 0.013	(-0.022,	0.049) 0.031 (0.001, 0.062)
eGfrcys N=2726
			Model	I 0.204 (0.168, 0.240) -0.248 (-0.283, -0.213) -0.157 (-0.194, -0.120) -0.268 (-0.303, -0.233)
			Model	II 0.053(0.016, 0.090) -0.040 (-0.073, -0.007) -0.001	(-0.038,	0.036) -0.057 (-0.091, -0.024)
			Model	III 0.053(0.014, 0.092) -0.036 (-0.070, -0.001) 0.006	(-0.033,	0.045) -0.056 (-0.090, -0.021)
			Model	IV 0.039	(-0.002,	0.079) -0.033	(-0.069,	0.003) 0.003	(-0.038,	0.044) -0.050 (-0.087, -0.014)
eGfrcr N= 2717
			Model	I 0.100 (0.063, 0.136) -0.136 (-0.171, -0.100) -0.092 (-0.129, -0.055) -0.143 (-0.179, -0.107)
			Model	II -0.007	(-0.041,	0.027) 0.011	(-0.020,	0.041) 0.015	(-0.020,	0.049) 0.007	(-0.024,	0.038)
			Model	III 0.002	(-0.033,	0.036) 0.003	(-0.028,	0.034) 0.008	(-0.027,	0.043) -0.001	(-0.032,	0.031)






intake,	 smoking,	 total	 cholesterol,	 high	density	 lipoprotein	 cholesterol,	 lipid-lowering	medication,	 diabetes	
mellitus,	history	of	cardiovascular	disease,	and	body	mass	index.	Model	IV:	additionally	adjusted	for	eGFR-
crcys	in	analyses	with	albumin-to-creatinine	ratio	as	determinant,	and	additionally	adjusted	for	albumin-to-cre-
atinine-ratio	in	analyses	with	eGFRcr	or	eGFRcys.	Abbreviations: CI: confidence interval, eGFRcys: cystatin 
C based estimated glomerular filtration rate, eGFRcr: creatinine based estimated glomerular filtration rate, 








(n=9)	 the	 U-shaped	 association	 was	 not	 present	 anymore.	 Performing	 the	 analyses	
with	 eGFRcrcys	as	 the	determinant,	 the	 effect	 estimates	were	 intermediate	between	
two	separate	equations	of	eGFRcr	and	eGFRcys	and	resulted	in	borderline	significant	
findings	(table e-2).
figure 1	 shows	 age	 and	 sex	 adjusted	means	 of	 FA	 and	MD	 in	 three	 categories	 of	
kidney	 function.	We	observed	 a	 linear	 trend	between	different	 categories	 of	 kidney	
function	 and	 white	 matter	 microstructural	 DTI-parameters,	 reflecting	 worse	 white	
matter	microstructure	in	persons	with	worse	kidney	function	(p	for	trend	0.001	for	FA	
and	0.002	for	MD).
































subtle	measure	 of	white	matter	 disease	 compared	 to	macrostructural	MRI-markers.	
                           Kidney	function	and	white	matter	microstructure 
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first category: indicates	 eGFRcrcys	 >	 60	 mL/min/1.73	 m2 AND	 albumin-to-
creatinine	ratio	<	30	mg/g	(N=2320) 
Second category: indicates	 eGFRcrcys	 >	 60	mL/min/1.73	m2 AND	 albumin-to-
creatinine	ratio	>	30	mg/g	OR	eGFRcrcys	<	60	mL/min/1.73	m2 AND	albumin-to-
creatinine	ratio	<	30	mg/g	(N=179) 

















The	 associations	 persisted	 after	 adjusting	 for	 history	 of	 stroke	 and	 conventional	













figure 2. Association	of	A) ACR	and	B) eGFRcys with	FA	and	MD	in	specific	
tracts. Adjusted	 for	 age,	 sex,	 white	matter	 volume,	 intracranial	 volume,	 and	 log	
transformed	white	matter	lesion	volume. 
Tracts	with	 significant	 associations	 (after	 Bonferroni	 correction:	 p<3.6×10-3)	 are	 labelled	
and	coloured. 
Abbreviations: ACR:	 albumin-to-creatinine	 ratio,	 eGFRcys:	 cystatin	 C	 based	 estimated	
glomerular	 filtration	rate,	FA:	fractional	anisotropy,	MD:	mean	diffusivity,	ATR:	anterior	






















is	 a	 vascular	 risk	 factor,	 cystatin	C	may	 reflect	 inflammatory	 status	 independent	 of	
eGFR.	However,	in	this	study	adjusting	for	cardiovascular	risk	factors	as	well	as	an	
inflammatory	marker	(C-reactive	protein)	did	not	change	the	associations.

















the	 function	of	 the	cerebral	microcirculation	and	 the	blood	brain	barrier,	which	can	
contribute	to	cerebral	hypoperfusion	and	subsequently	white	matter	damage.1
In	 the	 tract-specific	analyses,	MD	seemed	 to	be	a	more	sensitive	marker	 for	 loss	of	
white	matter	microstructural	 integrity	 in	 relation	 to	 kidney	 function.	This	might	 be	
explained	by	the	prevailing	theory	that	less	uniform	changes	in	FA	are	seen	in	deterio-
ration	of	crossing	fibers	regions,21	in	contrast	to	MD	that	may	show	more	consistent	




the	 brain	 and	 intact	 white	 matter	 integrity	 plays	 an	 essential	 role	 in	 these	 interac-
tions.14,	 22	 In	 line	with	 this	 notion,	we	 previously	 showed	 that	 early	 changes	 in	 the	












was	 not	 being	 fully	 incorporated	 in	 the	field	 of	 view	of	 the	 diffusion	 scan,	making	
conclusion	on	brain	stem	tracts	less	reliable.	In	addition,	our	findings	are	based	on	a	
population-based	study	including	relatively	young	and	healthy	individuals.	Prevalence	
of	kidney	disease	 in	 this	population	 is	 low	and	hence	 the	associations	are	based	on	






















































	 20.	 Thompson	CS,	Hakim	AM.	Living	 beyond	 our	 physiological	means:	 small	 vessel	 disease	 of	 the	
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Retinal	 arteriolar	 and	 venular	 calibers	were	measured	 semiautomatically	 on	 fundus	
photographs.	White	matter	microstructure	was	assessed	using	diffusion	 tensor	MRI.	






decrease	 in	 arteriolar	 caliber	 -0.061	 (95%	 confidence	 interval	 (CI):	 -0.106;	 -0.016)	














































the	 current	 study,	 2,436	 persons	were	 included	With	 available	DT-MRI	 and	 retinal	
data.
Standard protocol approvals, registrations, and patient consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	
to	 the	 Population	 Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	Health,	
Welfare	and	Sports	of	the	Netherlands.	All	participants	gave	written	informed	consent.	
Baseline	home	interviews	and	examinations	were	performed	between	2005	and	2009.






for	 the	arteriolar	calibers	 (in	μm)	and	one	 for	 the	venular	calibers	 (in	μm)	 for	each	
participant.15	Subsequently,	we	adjusted	these	summary	measures	for	refractive	errors	
to	approximate	absolute	measures.11	We	verified	in	a	random	sub-sample	(n=100)	that	




Assessment of dt-MrI parameters
All	 brain	MRI	 scanning	was	 performed	 on	 a	 single	 1.5	Tesla	MRI	 scanner	 (Signa	
Excite,	GE	Healthcare,	Milwaukee,	Wisconsin).	Scan	protocol	details	 are	described	
extensively	elsewhere.16	For	DT-MRI,	we	performed	a	single	shot,	diffusion-weighted	
spin	 echoplanar	 imaging	 sequence	 with	 maximum	 b	 value	 of	 1,000	 s/mm2	 in	 25	
non-collinear	directions.	A	standardized	pipeline	was	used	to	preprocess	all	diffusion	
data,	 including	 correction	 for	 motion	 and	 eddy	 currents,	 and	 registration	 to	 tissue	
segmentation	to	obtain	global	mean	DT-MRI	measures	of	the	normal-appearing	white	
















brain	 tissue	 classification	 and	 white	 matter	 lesion	 segmentation.18,	 19	 The	 presence	







Assessment of cardiovascular risk factors
We	measured	 the	 systolic	 and	 diastolic	 blood	 pressure	 twice	 in	 sitting	 position	 at	
the	right	upper	arm	with	a	random-zero	sphygmomanometer.	The	mean	of	these	two	
readings	was	used	for	further	analysis.	We	calculated	the	body	mass	index	as	weight	
divided	 by	 height	 squared.	An	 automated	 enzymatic	 procedure	 measured	 the	 non-
fasting	 serum	 concentrations	 of	 total	 and	 high-density	 lipoprotein	 cholesterol.21	We	
defined	diabetes	mellitus	as	present	if	fasting	serum	glucose	concentration	was	≥7.0	
























body	 mass	 index,	 total	 and	 high-density	 lipoprotein	 cholesterol,	 diabetes	 mellitus,	
C-reactive	protein,	atherosclerotic	plaque	and	smoking	(model	3).	We	explored	effect	
modification	 by	 stratifying	 for	 age	 (median:	 56	 years),	 sex,	 hypertension,	 diabetes	





























but	 remained	 statistically	 significant.	Additional	 adjustments	 for	 cardiovascular	 risk	
factors	marginally	changed	the	results.
table 1. Characteristics	of	the	eligible	study	cohort

























Mean	diffusivity,	10-3 mm2/s 0.73	(0.02) -
Axial	diffusivity,	10-3 mm2/s 1.01	(0.02) -











for	variables	 in	model	3,	we	 found	 that	 the	 association	 for	 arterioles	with	MD	was	















fractional anisotropy Mean diffusivity Axial diffusivity Radial diffusivity
Arteriolar caliber, per Sd decrease
			Model	1 -0.121	(-0.166;	-0.077)	 0.108	(0.065;	0.150) 0.065	(0.022;	0.108) 0.119	(0.075;	0.162)
			Model	2 -0.061	(-0.104;	-0.018) 0.054	(0.015;	0.092) 0.032	(-0.006;	0.070) 0.059	(0.019;	0.099)
			Model	3 -0.061	(-0.106;	-0.016) 0.048	(0.007;	0.088) 0.025	(-0.016;	0.065) 0.055	(0.013;	0.097)
Venular caliber, per Sd increase
			Model	1 -0.086	(-0.130;	-0.043) 0.080	(0.038;	0.123) 0.045	(0.003;	0.087) 0.090	(0.048;	0.133)
			Model	2 -0.060	(-0.101;	-0.019) 0.054	(0.016;	0.091) 0.027	(-0.010;	0.064) 0.062	(0.023;	0.101)












markers	 of	 cerebral	microvascular	 damage.	Both	 narrower	 arterioles	 and	wider	 ve-
nules	were	significantly	associated	with	larger	white	matter	lesion	volumes.	Additional	
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Figure	1	shows	absolute	mean	differences	 in	FA	and	MD	by	 terti es	of	arteriolar	
and	 venular	 calibers	 (adjusted	 for	 age	 and	 sex).	 In	 stratified	 analyses	 (Figure	 2),	
adjusted	for	variables	in	model	3,	we	found	that the	association	for	arterioles	with	
MD	 was	 modified	 by	 hypertension	 (P-value	 for	 interaction=0.021),	 whereas	 for	
venules,	the	a sociations	with	FA	and	MD	wer 	in	both	cases	modified	by	sex	(P-
value	 for	 interaction=0.006,	 and	 0.034,	 respectively).	 With	 respect	 to	 diabetes	
mellitus,	 we	 observed	 that	 the	 effects	 of	 arterioles	 and	 venules	 on	 DT-MRI	
parameters	were	more	pronounced	in	persons	with	diabetes	mellitus.	However,	p-

































































white matter lesion volume Presence of cerebral 
microbleeds
Presence of lacunar infarcts
Difference in z-score (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Arteriolar caliber, per Sd decrease
			Model	1 0.145	(0.100;	0.189) 1.20	(1.04;	1.40) 1.34	(1.03;	1.75)
			Model	2 0.146	(0.104;	0.188) 1.15	(0.99;	1.34) 1.10	(0.84;	1.43)
			Model	3 0.101	(0.057;	0.145) 1.14	(0.97;	1.33) 1.10	(0.83;	1.45)
Venular caliber, per Sd increase
			Model	1 0.061	(0.018;	0.104) 1.09	(0.95;	1.26) 1.31	(1.02;	1.68)
			Model	2 0.059	(0.018;	0.100) 1.07	(0.92;	1.24) 1.17	(0.90;	1.52)













several	 large	 population-based	 studies	 have	 shown	 that	 retinal	microvascular	 dam-
age	 is	 related	 to	 subclinical	 and	 clinical	 vascular	 brain	 diseases.	Community-based	
cohorts	of	predominantly	healthy	people	have	shown	that	retinopathy	signs	were	as-
sociated	with	incident	stroke,	cognitive	decline	and	dementia.22,	23	Apart	from	clinical	
outcomes,	 these	 studies	 also	 showed	 that	 persons	with	 retinopathy	 signs	 had	more	
often	subclinical	microvascular	brain	damages	such	as	white	matter	lesions,	cerebral	
infarcts	and	cerebral	microbleeds.22-26	Overall	these	findings	suggest	that	both	retinal	
and	 cerebral	microvascular	 damage	may	 appear	 simultaneously	 as	 part	 of	 systemic	
microvascular	 disease	 with	 common	 pathogenesis.26	 However,	 signs	 of	 retinopathy	








Interestingly,	 cross-sectional	 data	 from	 the	 Rotterdam	 Study	 showed	 that	 the	 as-











Pathophysiologically,	 a	 narrow	 retinal	 arteriolar	 caliber	may	 reflect	 not	 only	 active	
vasoconstriction,	 but	 also	 systemic	 structural	 changes	 such	 as	 arteriolosclerosis.29 
These	 processes	may	 concomitantly	 occur	 in	 the	 brain,	 where	 they	 affect	 the	 abil-
ity	 of	 cerebral	 arterioles	 to	maintain	 control	 of	 local	 blood	flow.	Thus,	 predisposed	
areas	 as	 served	by	 these	vessels	may	 lead	 to	 ischemic	damage,	 and	 eventually	 to	 a	
state	of	chronic	hypoperfusion	of	the	white	matter	with	subsequent	demyelination	and	
axonal	 damage.12	 It	 has	 been	 shown	 that	 subtle	 changes	 in	 the	white	matter	 due	 to	
demyelination	and	axonal	damage	can	be	detected	using	DT-MRI.30	With	respect	to	the	
venous	system,	several	histopathological	studies	have	reported	venular	abnormalities	




































vasculature	 and	 white	 matter	 microstructure.	 Second,	 persons	 excluded	 from	 these	
analyses	had	a	slightly	worse	cardiovascular	risk	profile,	suggesting	a	limited	role	for	
selection	bias.	Third,	retinal	caliber	measurements	were	assessed	at	a	single	timepoint	




have	 influenced	our	associations	by	 introducing	 residual	confounding.	Furthermore,	
participants	 in	 the	 Rotterdam	 Study	 are	 mainly	 middle-class	 white	 persons,	 which	
limits	 the	 generalizability	 of	 our	 findings.	Also,	 due	 to	 the	 low	number	 of	 incident	
clinical	 endpoints	 (stroke/dementia)	 in	 this	 extended	 cohort,	 we	 were	 not	 able	 to	
examine	the	association	between	retinal	vascular	calibers	and	DT-MRI-markers	with	




healthy	 individuals,	 the	 large	 study	 size	 and	 available	 data	 on	macrostructural	 and	
microstructural	brain	imaging	markers,	enabling	us	to	assess	independent	associations.
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monary	Disease	 (COPD)	 and	 cognitive	 impairment.	We	 assessed	 the	 association	 of	





Rotterdam	Study,	 a	 population-based	 cohort	 study.	Diffusion-MRI	 and	probabilistic	












Conclusions Reduced	 lung	 function	 (even	within	 the	 normal	 range)	 is	 related	 to	

















in	 the	 anterior	 and	 subcortical	 regions	 of	 the	 brain	 compared	 to	 healthy	 controls.12 
All	 these	 findings	 suggest	 a	more	 regional	 degeneration	 pattern	 in	COPD	 patients.	
Regional	 imaging	markers	may	be	 therefore	more	 insightful	 than	global	assessment	
of	brain	morphology.	Previous	studies	investigating	regional	brain	changes	in	COPD	
patients	mainly	 focused	on	cerebral	grey	matter.	Studies	 focusing	on	cerebral	white	










the	 normal	 range	 and	 overt	 COPD)	 on	 tract-specific	 white	 matter	 microstructural	
integrity	 in	 a	 large	 population	 of	 2,405	middle	 aged	 and	 elderly	 persons	 from	 the	
population-based	Rotterdam	Study.15	We	hypothesized	 that	 reduced	 lung	 function	 is	
related	 to	poor	microstructural	 integrity,	 in	particular	 in	 the	association	 tracts,	since	










ing	 diffusion-MRI,	was	 implemented	 in	 the	 study	 protocol.18	 For	 the	 current	 study	
we	 included	4,493	non-demented	participants	with	 lung	function	data.	We	excluded	
468	 participants	with	 asthma.	Out	 of	 4,025	 participants,	 3,184	 had	 an	 interpretable	
forced	expiratory	volume	 in	one	 second	 (FEV1	 )	measurement.	Of	 them,	2,700	had	
a	 good	 quality	MRI	 scan.	We	 additionally	 excluded	 participants	 with	 a	 history	 of	
clinical	stroke	(N=65),	and	MRI-defined	cortical	 infarcts	 (N=13),	 resulting	 in	2,405	
participants	 in	 the	FEV1	analysis.	For	 the	COPD	analysis,	we	additionally	excluded	
participants	 with	 a	 spirometry	 report	 suggestive	 of	 a	 restrictive	 syndrome	 [	 FEV1/
forced	 expiratory	 vital	 capacity	 (FVC)	 ≥	 70%	 and	 FVC	<	 80%	predicted]	 (N=91),	
so	2,314	persons	were	included	in	the	COPD	analysis.	Out	of	2,314	participants	363	
persons	had	a	diagnosis	of	COPD.	Out	of	2,405	participants	2,125	persons	had	analyz-





Spirometry	and	diffusing	capacity	were	performed	around	 the	 time	of	 the	scan	date	
using	a	Master	Screen®	PFT	Pro	(CareFusion,	San	Diego,	CA)	by	trained	paramedical	




MrI acquisition and processing
























Assessment of global cognitive function
Global	 cognitive	 function	 was	 assessed	 constructing	 a	 g-factor	 using	 a	 principal	
component	analysis	based	on	5	different	cognitive	tests	tapping	into	different	cogni-




Cardiovascular	 risk	 factors	 (systolic	 and	 diastolic	 blood	 pressure,	 serum	 and	HDL-
cholesterol,	medication	use,	smoking,	diabetes)	were	assessed	based	on	 information	


















the	diffusion	scan,	 leading	 to	varying	coverage	of	one	of	 the	15	 tracts	 (medial	 lem-






We	performed	a	sensitivity	analysis	 repeating	 the	 tract-specific	analysis	with	exclu-
sion	 of	 all	 persons	with	COPD.	We	 performed	 this	 analysis	 to	 investigate	whether	
lung	 function	measures	 within	 the	 normal	 range	 also	 associated	 with	 white	matter	
microstructural	damage.	We	also	repeated	the	tract-specific	analysis	for	FEV1	and	the	
diffusing	capacity	with	the	exclusion	of	the	participants	with	a	spirometry	suggestive	
























FA	and	 lower	MD	 throughout	 the	brain,	but	most	prominently	 in	 the	association	 tracts	





















   GOLD C 11	(0.5)










Abbreviations: COPD: chronic obstructive pulmonary disease; GOLD: Global initiative for chronic Obstruc-
tive Lung Disease criteria; FEV1: forced expiratory volume during the first second; DLCO,c: diffusing capacity 
of the lungs using carbon monoxide corrected for the haemoglobin concentration; HDL: high-density lipopro-
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figure 1. Association	 of	 lung	 function	 measures	 and	 tract-specific	 diffusion-MRI	
measures.	Colors	reflect	t-values	of	the	linear	regression	model	per	unit	increase	of	the	lung	
function	 marker	 after	 adjustments	 for	 age,	 sex,	 macrostructural	 MRI	 markers,	 CES-D,	
score,	 smoking	 pack-years	 and	 other	 cardiovascular	 risk	 factors.	 Higher	 strength	 of	
association	 is	 depicted	 in	 darker	 red	 for	 positive	 associations,	 darker	 blue	 for	 negative	
associations.	 
 
Abbreviations: MCP: middle cerebellar peduncle, ML: medial lemniscus, CST: cortico-
spinal tract, ATR: anterior thalamic radiation, STR: superior thalamic radiation, PTR: 
posterior thalamic radiation, SLF: superior longitudinal fasciculus, ILF: inferior 
longitudinal fasciculus, IFO: inferior-fronto-occipital fasciculus, UNC: uncinate 
fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocampal part of 
cingulum, FMA: forceps major, FMI: forceps minor. FA: fractional anisotropy, MD: mean 
diffusivity, FEV1: forced expiratory volume in one second, DLCOc: diffusing capacity, 
COPD: ch onic obstructive pulmonary disease, FA  fractional anisotropy, MD: mean 
diffusivity, CES-D: Center for Epidemiology Depression Scale. 









Abbreviations: MCP: middle cerebellar peduncle, ML: medial lemniscus, CST: cortico-spinal tract, ATR: an-
terior thalamic radiation, STR: superior thalamic radiation, PTR: posterior thalamic radiation, SLF: superior 
longitudinal fasciculus, ILF: inferior longitudinal fasciculus, IFO: inferior-fronto-occipital fasciculus, UNC: 
uncinate fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocampal part of cingulum, FMA: 
forceps major, FMI: forceps minor. FA: fractional anisotropy, MD: mean diffusivity, FEV1: forced expiratory 
volume in one second, DLCOc: diffusing capacity, COPD: chronic obstructive pulmonary disease, FA: frac-





fractional anisotropy Mean diffusivity


















































































































































































































Abbreviations: COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume during the 
first second in l; DLCOc= diffusing capacity of the lungs using carbon monoxide corrected for the haemoglobin 





In	 the	voxel-based	analyses,	 a	higher	FEV1	 associated	with	both	a	higher	FA	and	a	
lower	MD	 in	 voxels	 of	 the	 corticospinal	 tract,	 anterior	 thalamic	 radiation,	 superior	
thalamic	radiation,	(all	projection	tracts),	inferior	longitudinal	fasciculus	(association	
tract),	forceps	major	(callosal	tract),	and	with	the	cingulate	gyrus	(limbic	system	tract).	
Furthermore,	 a	 higher	FEV1	 associated	with	 a	 lower	MD	 in	voxels	of	 the	posterior	
thalamic	radiation	(projection	tract),	superior	longitudinal	fasciculus,	inferior	fronto-
occipital	fasciculus,	uncinate	fasciculus	(all	association	tracts),	and	with	voxels	of	the	
forceps	minor	(callosal	tract)	(figure 3, panel A and B, Supplementary table 3).
A	higher	diffusing	capacity	associated	with	a	higher	FA	in	voxels	in	periventricular	and	
subcortical	white	matter,	and	with	a	lower	MD	in	subcortical	white	matter	(figure 3, 




2013	GOLD	classification	and	mean	diffusivity	 after	 adjusting	 for	 age,	 sex,	macro-
structural	MRI	markers,	CES-D	score,	smoking	and	other	cardiovascular	risk	factors.	
We	observed	that	persons	with	severe	COPD	(GOLD	group	D)	compared	to	persons	
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threshold	 for	 significance	was	defined	based	on	permutation	 tests.	Significant	 voxels	 (for	
FA	 p<	 5.91	 x	 10-8 for	MD	 p<	 6.49	 x	 10-8)	 are	 color-coded.	 Colors	 reflect	 t-values	 and	



























)	0.19	 (0.13;0.26).	Per	unit	 increase	of	 the	diffusing	capacity	 the	g-factor	 increased	
with	b	(95%	CI	):	0.18	(0.02;0.35),	after	adjustments	for	after	adjusting	for	age,	sex,	
intracranial	 volume,	 CES-D	 score,	 smoking,	 and	 other	 cardiovascular	 risk	 factors.	
Participants	with	COPD	had	a	lower	global	cognition:	b	(95%	CI	)	-0.11	(-0.21;0.00).	




GoLd A GoLd B GoLd C GoLd d
Brainstem tracts    
Middle	cerebellar	peduncle -0.04	(-0.18;0.09) -0.05	(-0.21;0.12) 0.27	(-0.24;0.78) 0.01	(-0.37;0.39)
Medial	lemniscus	 0.02	(-0.13;0.17) 0.13	(-0.06;0.32) 0.31	(-0.27;0.89) 0.62 (0.18;1.06)
Projection tracts 
Corticospinal	tract -0.02(-0.13;0.09) 0.07	(-0.04;0.15) 0.10	(-0.31;0.51) 0.39	(0.08;0.71)
Anterior	thalamic	radiation -0.04	(-0.11;0.03) 0.05	(-0.04;0.15) -0.25	(-0.53;0.03) 0.08	(-0.13;0.30)
Superior	thalamic	radiation -0.03	(-0.16;0.09) 0.04	(-0.12;0.20) -0.06	(-0.54;0.42) 0.18	(-0.18;0.54)
Posterior	thalamic	radiation -0.03	(-0.14;0.08) -0.07	(-0.21;0.06) 0.03	(-0.39;0.45) 0.10	(	-0.21;0.42)
Association tracts
Superior	longitudinal	fasciculus -0.04	(-0.14;0.07) 0.03	(-0.11;0.16) -0.09	(	-0.52;0.35) 0.49 (0.18;0.80)*
Inferior	longitudinal	fasciculus 0.02	(-0.08;0.12) -0.01	(-0.14;0.12) 0.23	(	-0.17;0.62) 0.37 (0.07;0.67)
Inferior	fronto-occipital	fasciculus 	0.00	(-0.10;0.11) 0.05	(-0.08;0.17) -0.11	(-0.49;0.28) 0.36 (0.08;0.66)
Uncinate	fasciculus -0.02	(-0.13;0.10) 0.10	(-0.04;0.25) -0.19	(-0.64;0.26) 0.48 (0.14;0.81)
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.02	(-0.12;0.15) 0.09	(-0.09;0.26) -0.25	(-0.79;0.28) 0.69 (0.28;1.09)*
Parahippocampal	part	of	cingulum -0.01	(-0.15;0.14) -0.03	(-0.21;0.15) -0.01	(-0.57;0.55) 0.01	(-0.42;0.43)
Fornix -0.03	(-0.12;0.06) 0.00	(-0.11;0.11) -0.06	(-0.40;0.29) -0.07	(-0.34;0.20)
Callosal tracts
Forceps	major 0.03	(-0.08;0.14) 0.00	(-0.14;0.14) 0.11	(-0.32;0.54) 0.11	(-0.22;0.43)




investigated	 tract	and	additionally	adjusted	 for	CES-D	score,	 smoking	pack-years	and	other	cardiovascular	
risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	antihypertensive	medication,	serum	cholesterol,	
HDL-cholesterol,	lipid	lowering	medication,	diabetes).	
Abbreviations: GOLD:Global Initiative for Chronic Obstructive Lung Disease criteria; CI: confidence inter-
val; WM: white matter; WMH: white matter hyperintensities; CES-D: Center for Epidemiology Depression 











with	 COPD,	 however	 some	 of	 the	 associations	 were	 not	 (statistically)	 significant	
anymore	upon	multiple	comparisons	correction	(Supplementary table 2).
We	 furthermore	 repeated	 the	 tracts-specific	 analysis	 with	 FEV1	 and	 the	 diffusing	
capacity	as	determinant,	with	the	exclusion	of	all	participants	with	a	spirometry	sug-
gestive	of	a	restrictive	syndrome	(N=91).	The	estimates	did	not	change	substantially.	
However,	 again,	 some	of	 the	 associations	were	not	 statistically	 significant	 anymore	
(Supplementary table 3).
table 4. Association	of	lung	function	and	global	cognition	(g-factor)
Variable G-factor Model 1
b (95% CI )
G-factor Model 2





Model	 I:	Adjusted	 for	 age,	 sex,	 intracranial	volume.	Model	 II:	Model	 I	 and	additionally	 for	CES-D	score,	
smoking	pack-years	and	other	cardiovascular	risk	factors	(systolic	blood	pressure,	diastolic	blood	pressure,	
antihypertensive	medication,	serum	cholesterol,	HDL-cholesterol,	lipid	lowering	medication,	diabetes).	
Abbreviations: COPD: Chronic Obstructive Pulmonary disease; CI: confidence interval; DLCOc= diffusing 
capacity of the lungs using carbon monoxide corrected for the haemoglobin concentration; FEV1: forced ex-
piratory volume during the first second in l; DLCOc= diffusing capacity of the lungs using carbon monoxide 




Model I Model II
G-factor in CoPd + G-factor in CoPd – G-factor in CoPd + G-factor in CoPd -
Brainstem tracts   
Middle	cerebellar	peduncle -0.05	(-0.15;0.06) 0.01	(-0.04;0.05) -0.05	(-0.15;0.05) 0.00	(-0.05;0.04)
Medial	lemniscus -0.07	(-0.17;0.02) 0.00	(-0.04;0.04) -0.06	(-0.15;0.04) 0.00	(-0.04;0.04)
Projection tracts
Corticospinal	tract -0.23 (-0.36;-0.10)* -0.08 (-0.14;-0.02) -0.21 (-0.35;-0.07) -0.06 (-0.12;0.00)
Anterior	thalamic	radiation -0.28 (-0.49;-0.08) -0.16 (-0.25;-0.07)* -0.27 (-0.47;-0.07) -0.15 (-0.23;-0.06)*
Superior	thalamic	radiation -0.32 (-0.54;-0.11) -0.11 (-0.19;-0.02) -0.27 (-0.47;-0.06) -0.08	(-0.17;0.01)
Posterior	thalamic	radiation -0.13	(-0.27;0.00) -0.05	(-0.10;0.01) -0.12	(-0.25;0.01) -0.04	(-0.10;0.01)
Association tracts
Superior	longitudinal	
fasciculus -0.14 (-0.28;-0.01) -0.07 (-0.12;-0.01) -0.13	(-0.26;0.01) -0.05	(-0.11;0.00)
Inferior	longitudinal	
fasciculus -0.11	(-0.24;0.03) -0.11 (-0.17;-0.06)* -0.10	(-0.23;0.03) 0.10 (0.16;0.04)*
Inferior	fronto-occipital	
fasciculus -0.10	(-0.23;0.03) -0.10 (-0.15;-0.04)* -0.11	(-0.24;0.03) -0.08 (-0.14;-0.03)*
Uncinate	fasciculus -0.14 (-0.25;-0.02) -0.10 (-0.15;-0.05)* -0.12	(-0.24;0.00) -0.09 (-0.14;-0.04)*
Limbic system tracts
Cingulate	gyrus	part	of	
cingulum -0.14 (-0.24;-0.04) -0.07 (-0.11;-0.03)* -0.13 (-0.23;-0.03) -0.06 (-0.10;-0.01)
Parahippocampal	part	of	
cingulum -0.06	(-0.17;0.04) -0.06 (-0.10;-0.02) -0.06	(-0.16;0.04) -0.06 (-0.10;-0.02)
Fornix -0.21 (-0.38;-0.04) -0.07	(-0.13;0.00) -0.19 (-0.36;-0.03) -0.06	(-0.13;0.01)
Callosal tracts
Forceps	major -0.04	(-0.17;0.09) -0.05	(-0.10;0.01) -0.07	(-0.20;0.05) -0.04	(-0.10;0.01)
Forceps	minor -0.13 (-0.25;-0.01) -0.11 (-0.16;-0.06)* -0.11	(-0.21;0.01) -0.10 (-0.15;-0.05)*


























compared	 to	25	controls.29	However,	 the	differences	 in	white	matter	microstructural	
damage	between	 these	COPD	patients	 and	controls	were	no	 longer	 significant	 after	
adjustments	 for	 smoking,	 cerebrovascular	 comorbidity	 and	 cognition.	 Two	 other	
diffusion-MRI	 studies,	 using	 a	 voxel-based	 approach	 concluded	 that	 COPD	 could	










contributing	 to	both	microvascular	 and	macrovascular	 damage.31	However,	 it	 is	 not	
known	 to	what	 extent	 these	mechanisms	 can	 also	 explain	 the	 association	we	 found	
between	reduced	lung	function	parameters	within	the	normal	range	and	poorer	white	
matter	microstructure.
The	main	novelty	of	our	paper	 is	 that	we	 investigated	 the	association	between	 lung	














(mainly	 in	 the	association	 tracts)	compared	 to	persons	without	COPD.	This	finding,	
together	with	 the	fact	 that	 the	strongest	associations	between	diffusing	capacity	and	
white	matter	microstructure	are	seen	in	the	association	tracts,	points	toward	hypoxia/








ing	 the	 results	 of	 the	 tract-specific	 analysis	with	 the	 voxel-based	 analysis.	 For	 FA,	
however,	 we	 found	 in	 the	 tract-specific	 analysis	 different	 significant	 associations	
between	FEV1	and	white	matter	microstructure	compared	to	the	voxel-based	analysis	
(mainly	no	significant	associations	with	the	projection	tracts,	but	more	significant	as-
sociations	with	 the	associations	 tracts	and	callosal	 tracts).	Furthermore,	 for	both	FA	
and	MD,	we	 found	 in	 the	 tract-specific	 analysis	 with	 diffusing	 capacity	 significant	
associations,	 in	 particular	 in	 the	 association	 tracts,	 and	 there	 we	 no	 significant	 as-
sociations	in	the	voxel-based	analysis.	Explanations	for	these	differences	may	be	that	
by	 averaging	 positive	 and	 negative	 voxels,	 as	we	 did	 in	 the	 tract-specific	 analysis,	
significant	 associations	can	go	undetected.	On	 the	other	hand,	 a	major	downside	of	
exploring	associations	on	a	voxel-wise	level	is	multiple	comparisons	corrections,	mak-
ing	this	method	less	sensitive	to	very	small	changes.	Therefore,	we	chose	to	conduct	
both	methods	 and	 present	 them	 in	 parallel,	 as	we	 feel	 they	 convey	 complementary	
information.
Different	 white	 matter	 tracts	 have	 a	 variable	 susceptibility	 to	 decline,35,36	 possibly	
caused	by	 the	 location	of	 different	 tracts.	Association	 tracts	 connect	 different	 corti-







tive	 performance.38	 Poor	 white	matter	microstructural	 integrity	 of	 these	 tracts	may	
therefore	be	an	important	link	between	COPD	and	cognitive	impairment.




measurements	 were	 performed	 with	 fully	 automated,	 publicly	 available	 methods.39 
Furthermore,	we	also	included	a	voxel-based	analysis.	However,	also	some	limitations	
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Background	Thyroid	 hormone	 (TH)	 is	 crucial	 during	 neurodevelopment	 but	 high	
levels	of	TH	have	been	linked	to	neurodegenerative	disorders.	No	data	on	the	associa-
tion	of	thyroid	function	with	brain	imaging	in	the	general	population	are	available.
Methods	We	therefore	 investigated	 the	association	of	 thyroid-stimulating	hormone	
and	 free	 thyroxine	 (FT4)	 with	 MRI-derived	 total	 intracranial	 volume,	 brain	 tissue	
volumes	and	diffusion	tensor	imaging	(DTI)	measures	of	white	matter	microstructure	
in	4,683	dementia-	and	stroke-free	participants	(mean	age	60.2,	range	45.6-89.9	years).






















However,	 the	effects	of	 thyroid	hormone	on	 the	brain	are	age	dependent	because	 in	
addition	 to	 its	 effects	 during	 development,	 thyroid	 hormone	 is	 also	 related	 to	 neu-
rodegeneration.	 In	 older	 adults,	 higher	 thyroid	 function	 has	 been	 associated	with	 a	
higher	 risk	 of	 neurodegenerative	 disorders	 and	 poorer	 cognition.5,6	A	meta-analysis	
of	cohort	studies	showed	that	higher	thyroid	function	is	associated	with	higher	risk	of	
cognitive	 impairment.7	We	previously	described	 an	 increased	 risk	of	 dementia	with	
high-normal	 to	high	 thyroid	function	and	a	protective	effect	of	 low	and	 low-normal	
thyroid	function.8	This	risk	did	not	seem	to	be	explained	by	cardiovascular	risk	fac-











association	of	 thyroid	function	and	diffusion	 tensor	 imaging	(DTI)	measures	related	

























We	 included	 all	 participants	 from	 the	Rotterdam	 Study,	 cohort	 I	wave	 3,	 cohort	 II	
wave	 I	 and	 cohort	 III	 wave	 I,	 with	 thyroid	 function	measurements,	MRI	measure-
ments	and	free	of	dementia	at	baseline	(n=5104).	We	excluded	248	participants	with	
prevalent	 stroke	 and	 with	MRI-defined	 cortical	 infarcts	 and	 173	 participants	 using	
thyroid	 function	 altering	medication	 (levothyroxine,	 anti-thyroid	drugs,	 amiodarone	
or	corticosteroids).	Final	study	population	included	4,683	participants	of	which	3,852	
also	had	DTI	measurements.









MrI acquisition and analysis
Multi-sequence	brain	MR	 Imaging	was	performed	on	 a	 1.5	 tesla	MRI	 scanner	 (GE	
Signa	Excite).	The	imaging	protocol	and	sequence	details	were	described	extensively	
elsewhere.11	Scans	were	automatically	 segmented	supra	 tentorially	 into	grey	matter,	
white	matter,	 cerebrospinal	 fluid	 (CSF)	 and	 background	 tissue.	 Intracranial	 volume	
(ICV)	 (excluding	 the	cerebellum	and	 surrounding	CSF)	was	estimated	by	 summing	
total	 grey	 and	white	matter	 and	CSF	 volumes.12	Total	 brain	 volume	was	 estimated	
by	 summing	 total	 grey	 and	white	matter	 volumes.12	A	post-processing	white	matter	
lesion	classification,	based	on	the	FLAIR	image	and	the	tissue	segmentation,	was	used	





FreeSurfer	 4.5.	This	 procedure,	 based	 on	 probabilistic	 information	 obtained	 from	 a	





shot,	 diffusion-weighted	 spin	 echo	 echo-planar	 imaging	 sequence	 was	 performed.	
Maximum	b-value	was	1000	s/mm2	in	25	non-collinear	directions	and	three	volumes	
were	 acquired	 without	 diffusion	 weighting	 (b-value	 =	 0	 s/mm2).	 For	 the	 diffusion	

















pressure	 lowering	 medication	 for	 the	 indication	 of	 hypertension	 was	 derived	 from	





divided	by	height	 in	meters	 squared.	History	 of	 diabetes	mellitus	was	 defined	by	 a	
repeated	 (two	measurements	within	one	year)	 impaired	 fasting	glucose	≥	7	mmol/L	
or	a	non-fasting	glucose	of	≥	11	mmol/L	(when	fasting	samples	were	absent)	or	use	





Mental	State	Examination	 (MMSE)20	 and	Geriatric	Mental	State	 schedule	 (GMS).21 












volume	measurements	were	 adjusted	 for	 age,	 sex,	 cohort,	 time	 between	 laboratory	
measurement	and	MRI	scan	and	intracranial	volume.	We	included	intracranial	volume	
as	a	covariate	in	our	model	to	correct	for	the	inter-individual	variability	in	head	size.24 



















Monte	 Carlo	method	 and	 pooled	 subsequently	 (IBM	SPSS	 Statistics	 for	Windows,	
version	21.0.	Armonk,	NY).	In	our	multiple	comparisons	correction	we	took	the	main	














We	 included	 a	 total	 of	 4683	participants,	with	 an	 average	 age	 of	 60.2	 years	 (range	






Brain tissue volumes and intracranial volume
Higher	FT4	 levels	were	associated	with	 larger	 intracranial	volume	with	a	beta	 (b)	of	
6.23	mL	per	one	unit	increase	of	FT4	pmol/L	(95%	Confidence	Interval	[CI],	2.80,	9.66,	
table 2),	 and	 the	 association	was	 not	 different	 according	 to	 age	 (figure 1,	Supple-
mental table 1,	Supplemental table 2).	There	was	no	association	of	TSH	levels	with	
intracranial	volume.	Higher	FT4	levels	were	associated	with	larger	brain	volume	overall	
(b	2.26,	CI,	1.10,	3.43,	table 2)	and	white	matter	volume	in	particular	(b	1.43,	CI,	0.25,	
































Abbreviations: BMI = body-mass index; TSH = thyroid-stimulating hormone, FT4 = free thyroxine; SD = 
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Plot	 A)	 depicts	 the	 association	 of	 FT4with	 intracranial	 volume	 and	 plot	 B)	 depicts	 the	
association	of	FT4	with	total	brain	volume.	Plot	C)	depicts	the	interaction	of	FT4	with	age	
continuously	 for	 the	 intracranial	 volume	 analysis	 and	D)	 depicts	 interaction	 of	 FT4	with	
age	continuously	for	the	total	brain	volume	analysis.	All	analyses	are	adjusted	for	age,	sex,	
cohort	 and	 time	 between	 laboratory	measurements	 and	MRI	 scan,	 and	 the	 analyses	with	
brain	volume	were	additionally	adjusted	for	intracranial	volume. 
figure 1. Total	intracranial	and	brain	volume	according	to	FT4	serum	values










Variable total intracranial 
volume 
b (95% CI )
total brain  
volume
b (95% CI )
total white matter 
volume
b (95% CI )
total grey matter 
volume
b (95% CI )
TSH
			Model	1 0.39	(-2.32,	3.09) -1.37	(-2.28,	-0.46) -1.58	(-2.50,	-0.67) 0.21	(-0.59,	1.01)
			Model	2 0.64	(-2.04,	3.32) -1.37	(-2.27,	-0.47) -1.55	(-2.47,	-0.63) 0.18	(-0.61,	0.98)
FT4
			Model	1 7.23	(3.78,	10.67) 1.95	(0.78,	3.12)* 1.43	(0.25,	2.61) 0.47	(-0.55,	1.49)













total white matter 
volume
b (95% CI)
total grey matter 
volume
b (95% CI)
Reference range* (n= 4,141)
TSH		Model	1 -0.91	(-5.40,	3.58) -1.40	(-2.89,	0.09) -1.88	(-3.40,	-0.35) 0.48	(-0.84,	1.81)
					Model	2 -0.87	(-5.34,	3.59) -1.30	(-2.78,	0.17) -1.76	(-3.28,	-0.22) 0.45	(-0.87,	1.78)
FT4		Model	1 8.31	(4.25,	12.36) 2.32	(0.87,	3.76)** 1.56	(0.07,	3.04) 0.60	(-0.60,	1.80)
					Model	2 7.17	(3.12,	11.22) 2.53	(1.09,	3.97)** 1.41	(-0.08,	2.90) 0.99	(-0.22,	2.20)
Excluding participants with time interval between laboratory measurement and MRI scan > 1 years (n= 2,527)
TSH		Model	1 1.42	(-2.7,	5.56) -1.41	(-2.74,	-0.08) -1.22	(-2.55,	0.11) -0.24	(-1.42,	0.49)
						Model	2 1.54	(-2.57,	5.65) -1.50	(-2.82,	-0.17) -1.23	(-2.57,	0.11) -0.30	(-1.48,	0.88)
FT4		Model	1 6.78	(1.95,	11.61) 2.57	(1.01,	4.13)** 2.36	(0.79,	3.93) 0.08	(-1.29,	1.46)










White matter microstructural organization
There	was	no	overall	 association	of	TSH	or	FT4	with	diffusion	properties	of	white	
matter,	 neither	 FA	 nor	MD	 (table 4).	However,	 there	was	 a	 significant	 interaction	
with	 age	 for	 the	 association	 of	 FT4	 and	 MD	 (p	 for	 interaction	 0.026,	 figure 2,	
Supplemental table 1).	In	older	participants,	higher	FT4	values	were	associated	with	




integrity.	The	associations	 for	 radial	and	axial	diffusivity	 followed	 the	same	pattern	
as	mean	diffusivity	(figure 2).	All	results	survive	the	threshold	for	significance	after	




fA b (95% CI ) Md b (95% CI ) rd b (95% CI ) Ad b (95% CI )
TSH
			Model	1 -0.00(-0.03,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03)
			Model	2 -0.00(-0.03,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03) 0.01(-0.01,	0.03)
FT4
			Model	1 -0.01(-0.05,	0.02) 0.02(-0.01,	0.04) 0.01(-0.01,	0.04) 0.02(-0.01,	0.04)
			Model	2 -0.01(-0.04,	0.03) 0.01(-0.02,	0.04)	 0.01(-0.02,	0.04) 0.01(-0.01,	0.04)
Model	1:	age,	sex,	cohort,	time	between	laboratory	measurement	and	MRI	scan,	intracranial	volume,	white	
matter	 volume	 and	white	matter	 lesions.	Model	 2=	Model	 1	+	 total	 cholesterol,	HDL-cholesterol,	 systolic	
blood	pressure,	diastolic	blood	pressure,	blood	pressure	lowering	medication	with	indication	of	hypertension,	
smoking,	prevalent	diabetes,	BMI,	alcohol	use	and	educational	level.	Abbreviations: CI = confidence interval; 
FA = fractional anisotropy; FT4 = free thyroxine; MD = mean diffusivity; RD = radial diffusivity; AD = axial 
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age	 and	 deleterious	 in	 older	 age.	 To	 our	 knowledge,	 there	 are	 no	 previous	 studies	
assessing	 the	 association	 of	 thyroid	 function	 with	 brain	 volumes	 and	 white	 matter	
microstructure	 in	 the	general	population.	Based	on	our	 results,	we	hypothesize	 that	
the	findings	 in	younger	participants	could	reflect	a	positive	role	of	 thyroid	hormone	
balance	in	myelination,	sustainability	and	protection	of	neurons	during	early	stages	of	
life.	 In	contrast,	 in	older	age,	high	 thyroid	function	could	be	deleterious	by	causing	
neuronal	damage	and	in	turn	neurodegeneration.
Thyroid	hormone	is	 important	for	growth,	development	and	metabolism	in	virtually	
all	organs	and	effects	on	 the	brain	are	numerous.	Fetal	neurogenesis	 is	 thyroid	hor-
mone	dependent	and	both	lack	and	excess	of	thyroid	hormone	availability	can	hamper	
brain	development	and	has	deleterious	effects	on	brain	morphology.1,2,27	In	older	age,	
mainly	 high	 thyroid	 function	 has	 been	 linked	 to	 neurodegeneration	 and	 cognitive	
impairment.6,7,10	Higher	thyroid	hormone	levels	are	related	to	a	higher	basal	metabolic	


















adjusting	for	various	cardiovascular	 risk	 factors	 in	 the	current	study	did	not	change	
the	 associations	meaningfully.	This,	 together	with	 the	 current	 results,	 suggests	 that	
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Mild	 cognitive	 impairment	 (MCI)	 marks	 a	 transitional	 stage	 between	 healthy	 ag-





cross-sectionally	at	baseline	 (2002-2005)	and	up	 to	7	years	prior	 to	baseline	 (1997-
2001).	Secondly,	we	compared	volumetric,	microstructural,	and	focal	MRI-correlates	






white	 matter	 lesion	 volumes,	 worse	 microstructural	 integrity	 of	 normal-appearing	
white	matter,	 and	 a	 higher	 prevalence	 of	 lacunes,	 compared	 to	 cognitively	 healthy	
participants.	MCI	was	associated	with	an	increased	risk	of	dementia	(hazard	ratio	(HR)	















role	 of	 amyloid	 pathology	 in	MCI,	 but	 emerging	 evidence	 also	 implicates	 vascular	
factors	as	risk	factors	for	MCI.2-4	However,	findings	on	determinants,	MCI-correlates,	













Setting and study population

























determinants of MCI and other measurements
Determinants	of	MCI	were	selected	based	on	biological	plausibility	and	literature	on	
established	risk	factors	of	dementia.14-18	Educational	level	was	assessed	at	study	entry	
by	 interview	and	categorized	 into	 seven	groups:	primary	education	only	or	primary	
education	 with	 an	 unfinished	 higher	 education,	 lower	 vocational	 education,	 lower	
secondary	education,	intermediate	vocational	education,	general	secondary	education,	
higher	vocational	education,	and	university.	Since	educational	level	was	required	for	
assessment	 of	 the	MCI	diagnosis,	we	 imputed	missing	values	 for	 education	 (1.8%)	
based	on	age	and	sex.
Information	 on	 APOE	 genotype	 was	 obtained	 using	 polymerase	 chain	 reaction	 on	
coded	 DNA	 samples	 without	 knowledge	 of	MCI	 diagnosis.	 This	 method	 has	 been	













assessed	using	home	 interviews	and	confirmed	by	 reviewing	medical	 records.	After	
entering	the	Rotterdam	Study,	participants	were	continuously	followed-up	for	stroke	
























Briefly,	 compound	 score	 for	memory	was	 calculated	 as	 the	 average	of	Z-scores	 for	
the	immediate	and	delayed	recall	of	the	15-word	verbal	learning	test.	For	information	
processing	speed	averaged	Z-scores	for	the	Stroop	reading	and	Stroop	colour-naming	





MCI	was	defined	as	persons	with	MCI	who	had	an	 impaired	 test	 score	on	memory	
function	(irrespective	of	other	domains).	Non-amnestic	MCI	was	defined	as	persons	
with	MCI	having	normal	memory	function,	but	an	 impaired	 test	 score	on	executive	
function	or	information-processing	speed.










tensor	 imaging	scans	we	used	a	2D	acquisition	and	EPI	readout	 (slice	 thickness	for	
DTI	was	3.5	mm).	Maximum	b-value	was	1000	s/mm2	in	25	non-collinear	directions	
(number	 of	 excitations	 (NEX)=1)	 and	 one	 volume	 was	 acquired	 without	 diffusion	
weighting	(b-value=	0	s/mm2).
We	used	an	automated	tissue	segmentation,	including	conventional	k-nearest-neighbor	












mean	 diffusivity	 (MD),	measures	 of	microstructural	 integrity,	were	 computed	 from	








microbleeds	 and	 lacunes	 of	 presumed	 vascular	 origin.32	Microbleeds	were	 rated	 as	
focal	areas	of	signal	loss,	on	3D	T2*	Gradient	Recalled	Echo-weighted	MR	imaging.	
Lacunes	were	rated	on	FLAIR,	proton-density-weighted	and	T1-weighted	sequences,	











informant	 interview	 with	 the	 Cambridge	 Examination	 for	 Mental	 Disorders	 in	 the	
Elderly	 (CAMDEX).36	During	 this	 interview,	more	 information	on	 functional	 status	
and	cognitive	performance	was	collected.	Participants	who	were	suspected	of	having	
dementia	 underwent	 extra	 neuropsychological	 testing	 if	 necessary.	Additionally,	 for	
persons	not	visiting	the	research	center,	the	total	cohort	was	continuously	monitored	
for	dementia	through	computerized	linkage	of	the	study	database	and	digitized	medical	
records	 from	general	 practitioners	 and	 the	Regional	 Institute	 for	Outpatient	Mental	
Health	Care.	When	information	on	neuroimaging	was	required	and	available,	 it	was	
used	 for	decision	making	on	 the	diagnosis.	 In	 the	 end,	 a	 consensus	panel,	 led	by	 a	
neurologist,	 decided	 on	 the	 final	 diagnosis	 in	 accordance	with	 standard	 criteria	 for	
dementia	 (Diagnostic	 and	 Statistical	 Manual	 of	 Mental	 Disorders,	 Third	 Edition,	













vascular	 risk	 factors	 often	 correlate,17	 we	 estimated	 the	 independent	 effect	 of	 each	
risk	 factor	by	 including	all	 risk	 factors	 into	 the	 same	model.	Age	was	 included	per	









to	 investigate	 the	relation	of	MCI	with	volumetric	markers	(i.e.,	 total	brain	volume,	




Volumetric	 and	 microstructural	 measures	 were	 modeled	 continuously.	 Microbleeds	







volume.	 In	 addition	we	performed	 a	 sensitivity	 analysis	 for	 the	 imaging	 correlates,	
excluding	participants	who	became	demented	 in	 the	period	between	MCI	screening	
and	MRI	 scanning	 (N=12).	Thirdly,	we	used	Cox	proportional	hazards	 to	 study	 the	
association	 between	MCI	 and	 risk	 of	 dementia,	Alzheimer’s	 disease,	 and	mortality	
longitudinally.	These	models	were	 adjusted	 for	 the	 same	 determinants	 as	 described	
in	model	2	but	with	addition	of	prevalent	stroke	and	educational	 level.	All	analyses	
were	repeated	investigating	the	amnestic	and	non-amnestic	MCI	subtypes	separately.	





MCI.	Missing	 values	 for	 determinants	 of	MCI	 occurred	 in	 268	 participants	 (6.4%)	
in	2002-2005	 (baseline)	 and	 in	615	participants	 (14.6%)	 in	1997-2001.	Participants	






interval	 (CI)	 1.11;1.29),	APOE-ε4	 carriership	 (OR	 1.26,	 95%	CI	 1.00;1.59),	 lower	











current	 smoking	were	 related	 to	amnestic	MCI,	whereas	older	age	and	 lower	HDL-
cholesterol	levels	were	related	to	non-amnestic	MCI.
Out	 of	 682	 participants	with	MRI	 scanning,	 49	 screened	 positive	 for	MCI.	 Partici-
pants	with	MCI,	particularly	those	with	non-amnestic	MCI,	had	larger	WML	volumes	
compared	 to	 cognitively	 healthy	 participants	 (mean	 difference	 in	 log-transformed	
WML	 volume:	 0.36,	 95%	CI	 0.05;0.68).	 Persons	with	 non-amnestic	MCI	 also	 had	




































Age,	years 71.5	(7.1) 73.5	(7.5) 67.1	(7.0) 68.9	(7.4)
Females 58.2% 52.0% 58.1% 51.1%
APOE-ε4	carrier 26.2% 29.7% 26.2% 30.8%
Educational	level
			Primary	education 16.8% 24.8% 16.4% 23.8%
			Lower	vocational	education 20.2% 22.4% 20.3% 22.5%
			Lower	secondary	education 17.5% 9.2% 17.6% 9.4%
			Intermediate	vocational		education 26.7% 28.2% 26.8% 28.6%
			General	secondary	education 4.6% 1.9% 4.7% 2.0%
			Higher	vocational	education 12.7% 11.4% 12.7% 11.6%
			University 1.6% 1.9% 1.6% 2.0%
Waist	circumference,	cm 93.4	(11.8) 94.6	(12.4) 93.0	(11.5) 94.1	(11.9)
Hypertension 80.6% 83.0% 65.2% 70.9%
Diabetes	mellitus 14.1% 19.2% 8.3% 9.6%
Cholesterol,	mmol/l 5.65	(1.00) 5.43	(0.96) 5.84	(0.97) 5.75	(0.90)
HDL-cholesterol,	mmol/l 1.46	(0.40) 1.41	(0.40) 1.40	(0.39) 1.32	(0.36)
Smoking
			Former 55.1% 55.6% 50.4% 50.6%
			Current 15.1% 17.5% 19.0% 23.4%













































MCI Amnestic MCI Non-amnestic MCI
Odds ratio (95% CI)
n/N 389/3,541
Odds ratio (95% CI)
n/N 154/3,541
Odds ratio (95% CI)
n/N 235/3,541
Age,	per	5	years 1.20	(1.11;1.29) 1.04	(0.92;1.17) 1.30	(1.19;1.43)
Females 0.91	(0.70;1.17) 0.66	(0.45;0.98) 1.11	(0.80;1.54)
APOE-ε4	carrier 1.26	(1.00;1.59) 1.43	(1.01;2.02) 1.17	(0.86;1.58)
Waist	circumference,	per	SD 1.04	(0.92;1.18) 1.03	(0.84;1.25) 1.05	(0.90;1.24)
Hypertension 0.94	(0.70;1.25) 1.03	(0.66;1.59) 0.88	(0.61;1.28)
Diabetes	mellitus 1.24	(0.93;1.65) 1.44	(0.94;2.20) 1.11	(0.77;1.59)
Cholesterol,	per	SD 0.87	(0.78;0.98) 0.94	(0.79;1.11) 0.84	(0.73;0.97)
HDL-cholesterol,	per	SD 0.94	(0.83;1.06) 1.02	(0.84;1.23) 0.88	(0.75;1.04)
Smoking
			Former 0.96	(0.74;1.25) 1.08	(0.71;1.66) 0.90	(0.65;1.25)
			Current 1.21	(0.86;1.70) 1.37	(0.81;2.31) 1.13	(0.73;1.74)
Stroke 2.12	(1.40;3.19) 2.68	(1.51;4.76) 1.78	(1.04;3.03)
Values	represent	odds	ratios	and	95%	confidence	intervals,	adjusted	for	all	other	risk	factors.	
Abbreviations: MCI=mild cognitive impairment, CI=confidence interval, n=number of cases, N=number of 
controls, APOE=apolipoprotein E, SD=standard deviation, HDL=high-density lipoprotein.
table 3. Associations	between	risk	factors	of	dementia,	assessed	7	years	prior,	and	MCI.
MCI Amnestic MCI Non-amnestic MCI
Odds ratio (95% CI)
n/N 348/3,235
Odds ratio (95% CI)
n/N 140/3,235
Odds ratio (95% CI)
n/N 208/3,235
Age,	per	5	years 1.18	(1.11;1.29) 1.08	(0.95;1.23) 1.25	(1.13;1.38)
Females 0.93	(0.71;1.21) 0.75	(0.50;1.11) 1.08	(0.77;1.51)
APOE-ε4	carrier 1.35	(1.06;1.72) 1.54	(1.08;2.22) 1.23	(0.90;1.69)
Waist	circumference,	per	SD 1.02	(0.90;1.16) 1.02	(0.84;1.24) 1.03	(0.87;1.21)
Hypertension 1.17	(0.90;1.52) 1.00	(0.68;1.45) 1.33	(0.94;1.87)
Diabetes	mellitus 1.05	(0.72;1.54) 0.87	(0.46;1.62) 1.16	(0.73;1.84)
Total	cholesterol,	per	SD 0.95	(0.85;1.07) 0.94	(0.78;1.12) 0.96	(0.83;1.11)
HDL-cholesterol,	per	SD 0.86	(0.75;0.98) 0.95	(0.78;1.16) 0.80	(0.67;0.95)
Smoking
			Former 1.12	(0.84;1.49) 1.66	(1.01;2.73) 0.92	(0.65;1.31)
			Current 1.49	(1.06;2.09) 2.45	(1.41;4.24) 1.12	(0.73;1.73)
Stroke 2.50	(1.48;4.23) 2.91	(1.40;6.06) 2.22	(1.14;4.33)
Values	 represent	odds	 ratios	and	95%	confidence	 intervals,	adjusted	 for	all	other	 risk	 factors	and	addition-
ally	 for	 time	 between	measurements	 and	MCI	 diagnosis.	Abbreviations: MCI=mild cognitive impairment, 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































dementia Alzheimer’s disease Mortality
n/N Hazard ratio 
(95% CI)
n/N Hazard ratio 
(95% CI)
n/N Hazard ratio 
(95% CI)
Model I
No	MCI 149/3,781 	Reference 122/3,781 Reference 695/3,781 Reference
MCI 66/417 3.98	(2.97;5.33) 55/417 4.03	(2.92;5.56)	 132/417 1.54	(1.28;1.85)
			Amnestic	MCI 35/163 6.89	(4.74;10.01) 29/163 7.21	(4.77;10.89) 50/163 1.74	(1.30;2.31)
			Non-amnestic	MCI 31/254 2.65	(1.79;3.92) 26/254 2.69	(1.75;4.12) 82/254 1.44	(1.14;1.81)
Model II
No	MCI 140/3,541 Reference 114/3,541 Reference 653/3,541 Reference
MCI 59/389 3.70	(2.70;5.05) 49/389 3.75	(2.66;5.30) 123/389 1.48	(1.22;1.80)
			Amnestic	MCI	 33/154 6.76	(4.55;10.03) 27/154 7.20	(4.64;11.18) 46/154 1.58	(1.17;2.14)




Abbreviations: n=number of cases, N=number of persons at risk, CI=confidence interval, MCI=mild cognitive 
impairment.
dISCuSSIoN
We	 found	 that	 in	 the	 general	 population,	 older	 age,	 APOE-ε4	 carriership,	 lower	
total	cholesterol	levels,	and	prevalent	stroke	were	associated	with	MCI.	Lower	HDL-
cholesterol	 levels	 and	current	 smoking	were	only	 related	 to	MCI	when	assessed	up	










cross-sectional	 setting	 in	 the	 analyses	 of	 risk	 factors	 prevented	 inferring	 causality.	




















white	 matter,	 and	 a	 higher	 prevalence	 of	 lacunes	 compared	 to	 cognitively	 healthy	
participants.23,	41-43	As	regional	measurements	of	DTI	were	not	available	in	our	study,	
we	examined	DTI	measures	averaged	over	the	entire	normal	appearing	white	matter.	
For	 future	 investigations	 however,	 it	 would	 be	 interesting	 to	 study	 regional	 differ-
ences	in	FA	and	MD.	MCI	was	not	associated	with	total	brain	volume,	hippocampal	
volume,	 and	 cerebral	microbleeds.	These	 imaging	markers	 have	 been	 implicated	 in	
persons	with	MCI	before,44-49	 but	 relatively	 small	 sample	 size	hampered	our	 ability	




Participants	 with	MCI	 had	 an	 increased	 risk	 of	 dementia	 and	 an	 increased	 risk	 of	











load,	 altered	 diffusion	 tensor	 imaging	 measures,	 and	 lacunes,	 were	 more	 strongly	













with	 non-amnestic	MCI.	This	 difference	might	 be	 a	 consequence	 of	 the	 definitions	



















Anesthesia.	Vascular	contributions	 to	cognitive	 impairment	and	dementia:	a	statement	 for	health-
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CH.	 Introduction	 to	 the	 recommendations	 from	 the	National	 Institute	 on	Aging-Alzheimer’s	As-
sociation	workgroups	on	diagnostic	guidelines	for	Alzheimer’s	disease.	Alzheimers	Dement.	2011	
May;7(3):257-62.





























Age,	years 71.8	(7.2) 71.2	(7.2) 67.5	(7.0) 67.3	(7.0)
Females 57.0% 66.0%	a 56.3% 64.4%	a
APOE-ε4	carrier 26.5% 26.3% 26.9% 23.9%
Waist	circumference,	cm 93.5	(11.8) 94.5	(12.8)a 93.0	(12.3) 93.1	(11.5)
Hypertension 80.4% 86.9%	a 64.9% 72.1%	a
Diabetes	mellitus 14.4% 17.9% 8.6% 7.5%
Cholesterol,	mmol/l 5.62	(0.99) 5.79	(1.03) 5.84	(0.96) 5.76	(1.00)	a
HDL-cholesterol,	mmol/l 1.45	(0.40) 1.45	(0.40) 1.40	(0.39) 1.33	(0.36)
Smoking
			Former 55.5% 50.0% 51.2% 44.8%
			Current 15.2% 18.3% 19.0% 22.7%
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role	 of	 specific	 white	 matter	 tracts	 on	 top	 of	 a	 global	 white	 matter	 effect	 remains	
unclear,	 especially	when	 considering	 specific	 cognitive	 domains.	Therefore,	we	 de-
termined	 the	 tract-specific	effect	of	white	matter	microstructure	on	global	cognition	
and	 specific	 cognitive	 domains.	 In	 4,400	 nondemented	 and	 stroke-free	 participants	
(mean	 age	 63.7,	 55.5%	 female)	we	 obtained	 diffusion	magnetic	 resonance	 imaging	
parameters	(fractional	anisotropy	and	mean	diffusivity)	in	14	white	matter	tracts	us-
ing	 probabilistic	 tractography	 and	 assessed	 cognitive	 performance	with	 a	 cognitive	
test	battery.	Tract-specific	white	matter	microstructure	in	all	supratentorial	tracts	was	














regional	 pattern	 of	 association	 between	 these	macrostructural	white	matter	 changes	
and	specific	cognitive	domains.5-7	At	the	same	time,	it	is	thought	that	such	conventional	

































including	 diffusion-weighted	 MRI-scanning.	 We	 excluded	 scans	 with	 incomplete	
acquisitions	 (N=53),	 scans	with	artifacts	hampering	automated	processing	 (N=112),	
and	scans	with	MRI-defined	cortical	infarcts	(N=160).	We	additionally	excluded	116	








MrI acquisition and processing















Diffusion-MRI processing and tractography
For	diffusion-MRI,	we	performed	a	 single	 shot,	diffusion-weighted	 spin	echo	echo-














surements	was	 87%,	which	 is	 good.21	We	 standardized	 tract-specific	 diffusion-MRI	
parameters	(zero	mean,	unit	SD)	to	facilitate	comparison	of	associations.	Tracts	were	
categorized,	 based	 on	 anatomy,	 into	 brainstem	 tracts,	 projection	 tracts,	 association	
tracts,	limbic	system	tracts	and	callosal	tracts.21
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Tract	 segmentations	were	 also	 used	 to	 acquire	 tract-specific	white	matter	 volumes,	
and-	by	combining	the	 tissue	and	tract	segmentations-	 tract-specific	WML	volumes.	
Tract-specific	 WML	 volumes	 were	 natural-log	 transformed,	 to	 account	 for	 their	
skewed	distribution.
The	cerebellum	could	not	be	fully	incorporated	in	the	field	of	view	of	the	diffusion-
MRI	scan,	 resulting	 in	partial	coverage	of	 the	medial	 lemniscus	at	 the	 lower	border	
of	the	scan.	To	overcome	this	problem	alternative	seed	masks	for	tractography	were	
selected	 until	 reasonable	 coverage	was	 achieved.21	This	 correction	was	 treated	 as	 a	
potential	confounder	in	all	models	that	included	the	medial	lemniscus	(see	statistical	
analysis).







To	 aid	 comparison	 across	 cognitive	 tests	 we	 generated	 z-scores	 for	 each	 cognitive	
test.	The	z-scores	for	the	Stroop	tests	were	inverted:	higher	scores	on	the	Stroop	test	
indicate	a	poorer	performance,	while	higher	scores	on	the	other	cognitive	tests	indicate	
better	 cognitive	 performance.	 In	 addition,	we	 also	 investigated	 global	 cognition	 by	
constructing	 a	 g-factor	 using	 a	 principal	 component	 analysis	 on	 the	 delayed	 recall	
score	of	the	15-Word	Learning	Test,	Stroop	interference	Test,	Letter-Digit	Substitution	
Task,	Word	Fluency	Test,	and	the	Purdue	Pegboard	test.31




The	following	cardiovascular	 risk	 factors,	based	on	 information	derived	 from	home	
interviews	 and	 physical	 examinations	 during	 the	 center	 visit,	were	 assessed.	Blood	










(>=11.1	mmol/l)	 or	 the	 use	 of	 anti-diabetic	medication.19	The	 participants’	 attained	
level	of	education	was	collected	and	was	categorized	into	7	categories,	ranging	from	
primary	education	only	to	university	level.


































with	 a	 Mini	 Mental	 State	 Examination	 (MMSE)	 lower	 than	 26.	We	 corrected	 the	
Chapter	3.2
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factors	 and	APOE-ε4	 allele	 carriership,	 ranged	 from	 -0.16	 (CI:-0.20;-0.13)	 to	 -0.18	
(CI:-0.22;-0.14),	 in	 the	 association	 tracts	 from	 -0.11	 (CI:-0.14;-0.08)	 to	 -0.16	 (CI:-
0.20;-0.12).	After	controlling	for	global	FA	or	global	MD	(model	III),	the	associations	
attenuated	but,	the	majority	of	the	associations	remained	significant.
table 3	 presents	 the	 associations	 of	 white	 matter	 microstructure	 with	 cognitive	
performance	 on	 separate	 cognitive	 tests	 after	 adjustment	 for	 age,	 sex,	 education,	
intracranial	volume,	tract-specific	white	matter	volume,	tract-specific	WML	volume,	
cardiovascular	risk	factors	and	APOE-ε4	allele	carriership	(model	II).	Higher	values	
of	FA,	 in	 all	 tracts	 (except	 the	brain	 stem	 tracts),	 but	mainly	 in	 the	 inferior	 fronto-
occipital	fasciculus,	inferior	longitudinal	fasciculus	(association	tracts),	forceps	minor	
(callosal	tract)	and	the	posterior	thalamic	radiation	(projection	tract),	were	generally	























































Fractional Anisotropy Mean Diffusivity



































































































































































































the	 investigated	 tract.	Model	 II:	Model	 I,	and	additionally	adjusted	 for	cardiovascular	 risk	 factors	 (systolic	











association	 tracts	 remained	 significant,	with	 again	 the	 strongest	 associations	 for	 the	
inferior	fronto-occipital	fasciculus	and	the	posterior	thalamic	radiation.	We	did	not	find	
any	association	between	 tract-specific	microstructure	 and	memory	 (15-Word	Learn-
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figure 2. Diffusion-MRI	measures	and	global	cognition 
Mean	differences	in	z-score	of	global	cognition	for	all	14	white	matter	tracts	in	the	population,	presented	in	a	single	
subject	anatomy	for	visualization.	Colors	 reflect	 the	mean	differences	 in	z-score	per	SD	increase	of	FA	(row1)	or	
MD	 (row2),	 adjusted	 for	 age,	 sex,	 education,	 intracranial	 volume,	 tract-specific	WM	 volume,	 and	 tract-specific	
WML	 volume	 (model	 I).	 Model	 II	 is	 model	 I	 and	 additionally	 adjusted	 for	 cardiovascular	 risk	 factors,	 and	
apolipoprotein E-ε4 allele	carriership.	Model	III	adjusts	for	global	FA	or	global	MD	on	top	of	model	II. 
Higher	 strength	 of	 association	 is	 depicted	 in	 darker	 blue	 for	 positive	 associations,	 darker	 red	 for	 negative	
associations,	with	non-significant	associations	displayed	in	white. 
Abbreviations:	 FA;	 fractional	 anisotropy,	 MD;	 mean	 diffusivity,	 ICV;	 intracranial	 volume,	 WM;	 white	 matter,	
WML;	white	matter	lesion. 
 































Middle	cerebellar	peduncle 0.01 0.01 -0.03 -0.01 0.03 0.01 -0.02 0.02
Medial	lemniscusa 0.01 0.01 0.04  0.03 0.01 0.05 0.04 -0.01
Projection tracts
Corticospinal	tract -0.02 -0.01 0.00 0.02 0.01 0.03 -0.01 0.01
Anterior	thalamic	radiation 0.03 0.02 0.05 0.08 0.07 0.07 0.02 0.05
Superior	thalamic	radiation 0.00 0.01 0.01 0.02 0.03 0.02 0.00 0.01
Posterior	thalamic	radiation 0.01 -0.01 0.06 0.09 0.10 0.12 0.05 0.12
Association tracts
Superior	longitudinal	fasciculus 0.01 0.00 0.09 0.10 0.10 0.09 0.04 0.09
Inferior	longitudinal	fasciculus 0.01 -0.01 0.07 0.10 0.11 0.10 0.05 0.09
Inferior	fronto-occipital	fasciculus 0.01 -0.01 0.10 0.12 0.12 0.13 0.09 0.11
Uncinate	fasciculus -0.01 -0.01 0.03 0.05 0.05 0.06 0.03 0.05
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.00 -0.03 0.06 0.09 0.09 0.07 0.04 0.05
Parahippocampal	part	of	cingulum -0.01 0.00 0.04 0.05 0.06 0.03 0.08 0.04
Callosal tracts
Forceps	major 0.03 0.01 0.08 0.08 0.09 0.08 0.05 0.09
Forceps	minor 0.01 0.00 0.10 0.13 0.11 0.11 0.05 0.11
Md
Brainstem tracts
Middle	cerebellar	peduncle 0.00 0.00 -0.01 -0.01 -0.04 -0.01 0.00 0.01
Medial	lemniscusa 0.01 0.01 0.00 -0.02 -0.06 0.05 -0.02 -0.01
Projection tracts
Corticospinal	tract -0.04 -0.03 -0.09 -0.13 -0.13 -0.15 -0.10 -0.13
Anterior	thalamic	radiation -0.05 -0.05 -0.10 -0.13 -0.16 -0.14 -0.10 -0.10
Superior	thalamic	radiation -0.03 -0.03 -0.10 -0.13 -0.15 -0.15 -0.10 -0.12
Posterior	thalamic	radiation -0.05 -0.04 -0.11 -0.16 -0.18 -0.16 -0.11 -0.13
Association tracts
Superior	longitudinal	fasciculus -0.01 -0.02 -0.09 -0.11 -0.12 -0.13 -0.07 -0.09
Inferior	longitudinal	fasciculus -0.03 -0.02 -0.09 -0.12 -0.15 -0.12 -0.08 -0.10
Inferior	fronto-occipital	fasciculus -0.04 -0.03 -0.11 -0.14 -0.17 -0.14 -0.10 -0.14
Uncinate	fasciculus 0.01 -0.01 -0.04 -0.07 -0.10 -0.11 -0.07 -0.08
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.01 0.01 -0.02 -0.04 -0.07 -0.07 -0.05 -0.06
Parahippocampal	part	of	cingulum -0.02 -0.04 -0.01 -0.02 -0.07 -0.04 -0.06 -0.02
Callosal tracts
Forceps	major -0.01 -0.02 -0.09 -0.08 -0.11 -0.10 -0.07 -0.09
































Middle	cerebellar	peduncle 0.02 0.02 -0.03 -0.01 0.03 0.01 -0.02 -0.03
Medial	lemniscusa 0.01 0.01 0.03 0.01 -0.01 0.03 0.03 -0.03
Projection tracts
Corticospinal	tract -0.02 -0.01 -0.03 -0.02 -0.02 0.00 -0.01 -0.02
Anterior	thalamic	radiation 0.04 0.04 0.03 0.05 0.04 0.04 0.01 0.00
Superior	thalamic	radiation 0.00 0.01 -0.01 -0.01 0.01 0.00 -0.01 -0.03
Posterior	thalamic	radiation 0.02 0.00 0.04 0.06 0.08 0.10 0.05 0.08
Association tracts
Superior	longitudinal	fasciculus -0.01 0.01 0.07 0.08 0.06 0.08 0.05 0.05
Inferior	longitudinal	fasciculus 0.02 0.00 0.04 0.07 0.11 0.10 0.05 0.06
Inferior	fronto-occipital	fasciculus 0.01 -0.01 0.09 0.10 0.10 0.12 0.11 0.08
Uncinate	fasciculus -0.04 -0.02 -0.02 -0.02 -0.01 0.00 0.02 -0.01
Limbic system tracts
Cingulate	gyrus	part	of	cingulum -0.01 -0.03 0.03 0.06 0.06 0.05 0.03 0.01
Parahippocampal	part	of	cingulum -0.02 -0.01 0.03 0.03 0.04 0.01 0.07 0.02
Callosal tracts
Forceps	major 0.02 0.02 0.06 0.05 0.07 0.05 0.06 0.05
Forceps	minor -0.01 -0.01 0.07 0.08 0.07 0.08 0.03 0.07
Md
Brainstem tracts
Middle	cerebellar	peduncle 0.01 0.00 0.00 0.00 -0.02 0.01 0.01 0.02
Medial	lemniscusa 0.01 0.01 0.02 0.02 -0.03 0.00 -0.01 0.03
Projection tracts
Corticospinal	tract -0.05 -0.04 -0.11 -0.09 -0.11 -0.10 -0.08 -0.11
Anterior	thalamic	radiation -0.09 -0.08 -0.10 -0.10 -0.18 -0.09 -0.08 -0.08
Superior	thalamic	radiation -0.06 -0.06 -0.12 -0.11 -0.17 -0.10 -0.09 -0.10
Posterior	thalamic	radiation -0.06 -0.06 -0.11 -0.14 -0.18 -0.10 -0.10 -0.09
Association tracts
Superior	longitudinal	fasciculus -0.01 -0.05 -0.08 -0.06 -0.09 -0.06 -0.06 -0.05
Inferior	longitudinal	fasciculus -0.04 -0.06 -0.10 -0.08 -0.19 -0.05 -0.04 -0.07
Inferior	fronto-occipital	fasciculus -0.08 -0.09 -0.13 -0.11 -0.20 -0.06 -0.10 -0.13
Uncinate	fasciculus 0.04 -0.01 0.01 0.03 -0.03 -0.02 -0.03 -0.01
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.05 0.03 0.05 0.06 0.00 0.02 -0.02 0.01
Parahippocampal	part	of	cingulum -0.02 -0.06 0.01 0.02 -0.04 0.02 -0.04 0.00
Callosal tracts
Forceps	major -0.02 -0.02 -0.09 -0.04 -0.09 -0.04 -0.06 -0.04














In	 this	 study	 among	 middle-aged	 and	 elderly	 persons,	 altered	 tract-specific	 white	






We	 found	 tract-specific	 differences	 for	 associations	with	 cognitive	 function:	 among	
the	fourteen	white	matter	tracts	the	microstructural	integrity	in	the	posterior	thalamic	
radiation	 (projection	 tract)	 and	 the	 inferior	 fronto-occipital	 fasciculus	 (association	
tract)	were	most	strongly	associated	with	cognitive	performance.
Strengths	of	this	study	include	the	large	sample	size	and	the	population-based	setting.	
Furthermore,	 we	 performed	 a	 tract-specific	 analysis	 in	 fourteen	main	 white	 matter	
tracts,	 and,	 the	 tract-specific	 measurements	 were	 performed	 with	 fully	 automated,	
publicly	 available	 methods.38	 Some	 limitations	 need	 to	 be	 considered.	 Due	 to	 the	
cross-sectional	design,	no	conclusions	can	be	drawn	on	 the	directionality	of	causal-
ity	of	 the	associations.	Furthermore,	 the	evaluation	of	cognitive	performance	in	 this	

























with	 age	 was	 found.21	 In	 extension	 to	 this	 study,	 we	 now	 demonstrate	 that	 altered	
microstructural	 integrity	 of	 the	 same	 supratentorial	 tracts	 is	 associated	with	 poorer	










with	 poorer	 information	 processing	 speed	 and	 executive	 function,43-45,47,48	 and	 with	
































cognitive	 performance.	 In	 contrast,	 higher	 values	 of	 MD	 in	 the	 projections	 tracts	
were	most	strongly	associated	with	impaired	cognition.	The	disparity	in	associations	
between	FA,	MD	and	cognitive	performance	might	 indicate	 that	FA	and	MD	reflect	














MRI	 parameters.	 This	 study	 provides	 novel	 etiological	 insight	 into	 the	 relation	 of	
the	 location	of	brain	damage	and	cognitive	performance;	 in	other	words	 it	provides	
insight	 in	which	 tract	 influences	which	specific	cognitive	domain.	Second,	our	find-
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Background	 The	 ‘disconnectivity	 hypothesis’	 postulates	 that	 partial	 loss	 of	 con-
necting	white	matter	fibers	between	brain	regions	contributes	to	the	development	of	




diffusivity	 (MD)	 were	 obtained	 in	 4,415	 non-demented	 persons	 (mean	 age	 63.9	
years	 (SD	 11.0),	 55.0%	women)	 from	 the	 prospective	 population-based	 Rotterdam	
Study	with	brain	MRI	 (2005-2011).	We	modelled	 the	 association	of	 these	diffusion	
measures	with	risk	of	dementia	(follow-up	until	2016),	and	with	changes	on	repeated	
cognitive	assessment	over	5.4	years	of	 follow-up,	adjusting	 for	age,	 sex,	education,	
macrostructural	MRI	markers,	depressive	symptoms,	cardiovascular	risk	factors,	and	
APOE	genotype.
Findings	During	 a	mean	 follow-up	 of	 6.7	 years,	 101	 participants	 had	 incident	 de-
mentia,	 of	whom	83	had	AD.	Lower	global	values	of	FA	and	higher	values	of	MD	
associated	with	an	increased	risk	of	dementia	(adjusted	hazard	ratio	(95%	confidence	
interval)	per	 standard	deviation	 increase	 in	MD:	1.79	 (1.44-2.23)).	Similarly,	 lower	
global	values	of	FA	and	higher	values	of	MD	related	to	more	cognitive	decline	in	non-
demented	individuals	(difference	in	global	cognition	per	standard	deviation	increase	
























dementia,6	 and	 is	 thought	 to	 reflect	 early	 cerebral	white	matter	 damage.7,8	 Previous	
studies	have	shown	more	pronounced	disconnectivity	both	in	patients	with	dementia	
compared	to	healthy	controls,9,10	and	in	relation	to	more	rapid	progression	in	patients	
with	Alzheimer’s	 disease	 (AD).11	 However,	 evidence	 from	 longitudinal	 studies	 for	










This	 study	 was	 embedded	 within	 the	 Rotterdam	 Study,	 a	 population-based	 cohort	
study	 including	 participants	 of	 45	 years	 and	 older	 living	 in	Ommoord,	 a	 suburb	 of	
Rotterdam.14	 The	 study	 started	 in	 1990	 with	 7,983	 participants	 and	 was	 extended	
with	3,011	participants	in	2000	and	with	3,932	participants	in	2006.	Participants	were	








implants,	 pacemaker,	 claustrophobia)	 were	 eligible	 for	 scanning,	 of	 whom	 4,888	
(86%)	underwent	a	multi-sequence	MRI	acquisition	of	the	brain,	and	4,813	(98%)	par-



















summing	 total	 grey	 and	white	matter	 and	CSF	volumes.17	We	visually	 assessed	 the	
presence	of	 infarcts	on	conventional	MRI	sequences,	and	 in	case	of	 involvement	of	
cortical	grey	matter	we	classified	these	as	cortical	infarcts.
Diffusion-MRI processing and tractography
For	diffusion-MRI,	we	performed	a	 single	 shot,	diffusion-weighted	 spin	echo	echo-




resampled	data	was	used	 to	fit	diffusion	 tensors	 to	compute	mean	 fractional	 anisot-
ropy	(FA)	and	mean	diffusivity	(MD)	in	the	normal-appearing	white	matter,	through	
combination	with	the	tissue	segmentation.	The	diffusion	data	was	also	used	to	segment	






















lum	 in	 the	 field	 of	 view,	 and	we	 used	 alternative	 seed	masks	 for	 tractography	 and	
adjustment	in	the	model	to	overcome	this	problem.20
dementia screening and surveillance
All	participants	were	screened	for	dementia	at	baseline	and	during	subsequent	center	
visits	 using	 the	Mini-Mental-State	 Examination	 (MMSE)	 and	 the	 Geriatric	Mental	
Schedule	 (GMS)	 organic	 level.21	 Participants	with	 an	MMSE	 score	 <26	 or	 a	GMS	
score	 >0	 underwent	 further	 cognitive	 examination	 and	 informant	 interview,	 includ-
















number	 of	 correct	 digits	 in	 1	 minute),	 Stroop	 test	 (error	 adjusted	 time	 in	 seconds	
taken	 for	 completing	 the	 reading,	 colour	 naming,	 and	 interference	 tasks),	 and	 the	
Purdue	Pegboard	 task	for	manual	dexterity.21	To	obtain	a	composite	measure	of	 test	
performance,	 we	 calculated	 the	 G-factor	 by	 principal	 component	 analysis,21	 which	
explained	49-54%	of	variance	 in	cognitive	 test	scores	at	each	examination	round	 in	
our	population.	For	each	participant,	Z-scores	were	calculated	for	each	test	separately,	
by	dividing	the	difference	between	individual	test	score	and	population	mean	by	the	
population	 standard	 deviation.	 Scores	 for	 the	 Stroop	 tasks	 were	 inverted	 such	 that	
higher	scores	indicated	better	performance.
other measurements
Information	on	 smoking	habits,	 educational	 attainment,	 and	use	of	antihypertensive	
and	 lipid-lowering	 medication	 was	 ascertained	 at	 baseline	 by	 structured	 question-
naires.	Blood	 pressure	was	measured	 twice	 in	 sitting	 position	 using	 a	 random-zero	
sphygmomanometer	 and	 the	mean	 of	 two	 readings	was	 used	 in	 the	 analyses.	Total	
serum	cholesterol	and	high-density	lipoprotein	(HDL)	cholesterol	were	determined	in	
fasting	blood	samples.	Presence	of	type	2	diabetes	at	baseline	was	determined	on	the	








APOE	 genotype	 was	 determined	 using	 polymerase	 chain	 reaction	 on	 coded	 DNA	
samples	(original	cohort),	and	using	a	bi-allelic	TaqMan	assay	(rs7412	and	rs429358;	
expansion	 cohort).	 In	 179	 participants	 with	 missing	 APOE	 status	 from	 this	 blood	
sampling,	genotype	was	determined	by	genetic	imputation	(Illumina	610K	and	660K	




diffusion	 measures	 deviated	 >7	 standard	 deviations	 from	 the	 mean,	 leaving	 4,415	
167
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participants	 for	analysis.	We	used	Cox	proportional	hazard	models	 to	determine	 the	
association	 of	 global	 and	 tract-specific	 diffusion-MRI	measures	 (FA	 and	MD)	with	
incident	dementia.	The	proportional	hazard	assumption	was	met.	We	assessed	risk	of	
dementia	 per	 standard	 deviation	 increase	 in	 FA	 and	MD.	We	 repeated	 the	 analyses	
1)	 for	Alzheimer	 disease	 only,	 2)	 after	 excluding	 participants	with	 prevalent	 stroke	
while	 censoring	 at	 time	of	 incident	 stroke,	 3)	 excluding	persons	with	MRI-defined,	
subclinical	cortical	infarcts	at	baseline,	and	4)	stepwise	excluding	the	first	five	years	of	
follow-up	from	the	analysis.









serum	 cholesterol,	 HDL-cholesterol,	 lipid-lowering	 medication,	 diabetes,	 smoking,	
and	BMI),	and	APOE-ε4	allele	carriership	(model	II).
For	 the	 tract-specific	 analyses,	 we	 corrected	 the	 p-value	 (alpha	 level	 of	 0.05)	 for	
multiple	comparisons	with	the	number	of	independent	tests	on	the	basis	of	the	vari-
ance	of	the	eigenvalues	of	the	correlation	matrix	of	all	30	variables	used	in	the	main	
analysis	 (i.e.	FA	and	MD	for	 the	15	 tracts).	The	 following	 formula	was	used:	Meff= 
1	+(M-1)(1-var	(λobs)/M)	in	which	M	is	 the	number	of	variables,	λobs	 is	 the	variance	




For	 the	 analyses	 assessing	 global	 diffusion-MRI	measures	with	 the	 separate	 cogni-
tive	tests	as	outcome,	the	above-mentioned	method	generated	a	significance	level	of	
p<0.008.	 For	 analyses	 assessing	 tract-specific	 diffusion-MRI	 measures	 with	 global	
cognition	and	separate	cognitive	tests	as	outcome,	the	adjusted	p-value	was	p<0.0022.
All	 analyses	were	 carried	out	 using	SPSS	Statistics	 21.0	 (IBM	Corp,	Armonk,	NY,	







































Abbreviations: N:number of participants, HDL:high-density lipoprotein, BMI: body mass index, s;seconds, 






1.79	(1.44-2.23)	(figure 1, Supplementary table S1).	Results	were	similar	for	AD	only,	
and	unaltered	after	excluding	participants	with	prevalent	stroke	while	censoring	at	time	of	
incident	 stroke,	or	 excluding	participants	with	 subclinical	MRI-defined	cortical	 infarcts	
(figure 1, Supplementary table S1).	Stepwise	exclusion	of	the	first	five	years	of	follow-
up	from	the	analysis	did	not	alter	the	risk	estimates	(figure 2, Supplementary table S2).
In	tract-specific	analyses,	the	strongest	associations	with	dementia	risk	were	observed	
for	MD	 in	 the	projection	 tracts,	 association	 tracts	 and	 limbic	 system	 tracts	 (per	SD	
increase	HR	of	2.35	(1	.53;3.62)	for	the	superior	thalamic	radiation,	1.79	(1.36;2.37)	
for	the	inferior	fronto-occipital	fasciculus,	and	1.62	(1.41;1.86)	for	the	parahippocam-
pal	part	of	the	cingulum	respectively	(table 2, figure 3)).	Similarly,	lower	FA	in	the	
association	 tracts	 and	 in	 the	 limbic	 system	 tracts	 were	most	 profoundly	 associated	





hazard	 ratio	 [HR],	 95%	 confidence	 interval	 (CI),	 per	 SD	 increase	 in	 FA:	 0.65 
(0.52-0.80),	and	for	MD:	1.79	(1.44-2.23)	(figure 1, Supplementary table S1).	
Results	were	similar	 for	AD	only,	and	unaltered	after	excluding	participants	with	
prevalent	 stroke	 while	 censo ing	 at	 time	 of	 incident	 stroke,	 or	 excluding	
particip nts	 ith	 subclinical	 MRI-defined	 cortical	 infarcts	 (figure 1, 
Supplementary table S1).	Stepwis 	exclusion	of	the	first	five	years	of	follow-up	
from the	analysis	did	not	alter	th 	risk	estim tes	(figure 2, Supple entary table 
S2).	 
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hazard	 ratio	 [HR],	 95%	 confidence	 interval	 (CI),	 per	 SD	 increase	 in	 FA:	 0.65 
(0.52-0.80),	and	for	MD:	1.79	(1.44-2.23)	(figure 1, Supplementary table S1).	
Results	were	similar	 for	AD	only,	and	unaltered	after	excluding	participants	with	
prevalent	 stroke while	 censo ing	 at	 ti 	 of	 incident stroke,	 or	 excluding	
participants	 with	 subclinical	 MRI-defined	 cortical	 infarcts	 (figure 1, 
Supplementary table S1).	Stepwise	exclusion	of	the	first	five	years	of	follow-up	
from	the	analysis	did	not	alter	the	risk	estimates	(figure 2, Supplementary table 
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dementia	 cases	 (Supplementary table S3).	 Similar	 associations,	 albeit	 somewhat	
attenuated,	were	observed	for	FA.
table 2. Tract-specific	white	matter	microstructure	and	incident	dementia
Fractional Anisotropy Mean Diffusivity
white matter tracts Model I Model II Model I Model II
Brainstem tracts
Middle	cerebellar	peduncle 1.05	(0.85;1.30) 1.08	(0.87;1.35) 1.05	(0.85;1.30) 1.04	(0.83;1.30)
Medial	lemniscus	 1.09	(0.86;1.39) 1.11	(0.86;1.44) 1.06	(0.88;1.28) 1.06	(0.87;1.29)
Projection tracts 
Corticospinal	tract 1.17	(0.95;1.44) 1.19	(0.96;1.47) 1.52 (1.13;2.06) 1.52 (1.11;2.08)
Anterior	thalamic	radiation 0.85	(0.66;1.09) 0.87	(0.67;1.13) 1.68 (1.23;2.30)* 1.73 (1.26;2.38)*
Superior	thalamic	radiation 1.17	(0.95;1.45) 1.20	(0.97;1.50) 2.29 (1.49;3.52)* 2.35 (1.53;3.62)*
Posterior	thalamic	radiation 0.69 (0.52;0.90) 0.74 (0.56;0.97) 1.41 (1.15;1.72)* 1.42 (1.15;1.75)*
Association tracts
Superior	longitudinal	fasciculus 0.77	(0.60;1.00) 0.79	(0.60;1.04) 1.65 (1.30;2.11)* 1.65 (1.28;2.14)*
Inferior	longitudinal	fasciculus 0.79	(0.62;1.01) 0.84	(0.65;1.09) 1.73 (1.36;2.21)* 1.69 (1.31;2.18)*
Inferior	fronto-occipital	fasciculus 0.66 (0.50;0.86)* 0.71 (0.53;0.93) 1.75 (1.34;2.27)* 1.79 (1.36;2.37)*
Uncinate	fasciculus 0.60 (0.47;0.77)* 0.59 (0.45;0.76)* 1.67 (1.39;2.00)* 1.73 (1.42;2.10)*
Limbic system tracts
Cingulate	gyrus	part	of	cingulum 0.69	(0.54;0.87) 0.71 (0.55;0.90) 1.55 (1.26;1.92)* 1.58 (1.26;1.97)*
Parahippocampal	part	of	cingulum 0.67 (0.54;0.84)* 0.67 (0.53;0.84)* 1.61 (1.41;1.85)* 1.62 (1.41;1.86)*
fornix 0.76 (0.59;0.99) 0.78	(0.60;1.02) 1.13	(0.80;1.58) 1.06	(0.75;1.50)
Callosal tracts
Forceps	major 0.77 (0.59;1.00) 0.79	(0.61;1.04) 1.15	(0.93;1.41) 1.12	(0.90;1.38)





blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	medication,	 serum	cholesterol,	HDL-cholesterol,	
lipid	lowering	medication,	diabetes,	smoking,	BMI)	and	apolipoprotein E-ε4 allele	carriership.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, WML: white matter lesion, BMI: Body Mass 
Index, CES-D: Center for Epidemiology Depression Scale score.
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Tracts	 that	 were	 significantly	 associated	 with	 dementia	 risk	 are	 color-coded,	 as	 represented	 in	 the	
color	legend.	Other	tracts	are	presented	in	grey.	 
Abbreviations:, ATR: anterior thalamic radiation, STR: superior thalamic radiation, PTR: posterior 
thalamic radiation, SLF: superior longitudinal fasciculus, ILF: inferior longitudinal fasciculus, IFO: 
inferior-fronto-occipital fasciculus, UNC: uncinate fasciculus, CGC: cingulate gyrus part of 






Abbreviations:, ATR: anterior thalamic radiation, STR: superior thalamic radiation, PTR: posterior thalamic 
radiation, SLF: superior longitudinal fasciculus, ILF: inferior longitudinal fasciculus, IFO: inferior-fronto-
occipital fasciculus, UNC: uncinate fasciculus, CGC: cingulate gyrus part of cingulum, CGH: parahippocam-
pal part of cingulum.
table 3. Global	white	matter	microstructure	and	cognitive	decline
fA Md
G-factor 0.02	(-0.004;0.041) -0.04 (-0.07;-0.01)
Immediate	memory -0.002	(-0.04;0.03) -0.03	(-0.07;0.02)
Delayed	memory 0.007	(-0.03;0.04) -0.03	(-0.07;-0.01)
Stroop	1 0.04 (0.01;0.07)* -0.06 (-0.09;-0.02)*
Stroop	2 0.02	(-0.001;0.05) -0.02	(-0.05;0.02)
Stroop	3 0.04 (0.01;0.07)* -0.09 (-0.12;-0.05)*
Letter-Digit	Substitution	Task 0.004	(-0.02;0.03) -0.004	(-0.04;0.03)
Word	Fluency	Test 0.03	(0.001;0.06) -0.06 (-0.10;-0.02)*
Purdue	Pegboard 0.03 (0.005;0.06) -0.04	(-0.07;-0.00)
Data	are	presented	as	mean	difference	in	Z-score	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	
Results	in	bold	were	significant	at	p<0.05	and	those	that	were	starred	*	at	p<0.008.
Model	 adjusted	 for	 age,	 sex,	 education,	 intracranial	volume,	white	matter	volume	and	 the	 log	 transformed	
white	matter	lesion	volume,	CES-D	score,	and	additionally	adjusted	for	cardiovascular	risk	factors	(systolic	
blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	medication,	 serum	cholesterol,	HDL-cholesterol,	
lipid	lowering	medication,	diabetes,	smoking,	BMI)	and	apolipoprotein E-ε4 allele	carriership.
Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, WML: white matter lesion, BMI: Body Mass 




In	 this	 longitudinal	population-based	study,	we	found	 that	structural	disconnectivity	
is	 associated	with	 increased	 risk	 of	 dementia	 and	with	more	 pronounced	 cognitive	
decline.	These	 associations	were	most	 profound	 for	 the	 projection,	 association	 and	
limbic	system	tracts,	and	extended	into	the	pre-clinical	phase	of	the	disease.
Longitudinal	 studies	 provide	 higher	 evidence	 for	 causal	 relations.	Our	main	 results	
provide	 evidence	 for	 the	 ‘disconnection	hypothesis’,	which	 states	 that	 loss	of	brain	
connections	 precedes	 cognitive	 decline	 and	 dementia.	 In	 line	 with	 this	 hypothesis,	
our	results	suggest	 that	disconnectivity	plays	a	role	already	in	 the	preclinical	stages	






























A	 small	 number	of	 studies	 reported	higher	FA	values	 in	 specific	 regions	 in	AD.38,39 
This	 counterintuitive	finding	may	be	 explained	 by	 selective	 degeneration	 of	 a	 fiber	
population	in	regions	with	crossing	white	matter	tracts,	leading	to	paradoxical	higher	





The	 exact	 pathological	 substrate	 underlying	 the	 changes	 in	 FA	 and	MD	 leading	 to	
disconnectivity	 is	 still	 unknown.	 There	 is	 pathological	 evidence	 that	 changes	 in	
diffusion-MRI	measures	correlate	with	myelin	damage	and	axonal	count,42	that	myelin	
is	 increasingly	 suggested	 as	 an	 important	 factor	 in	AD	 pathology	 and	 that	 myelin	
breakdown	 is	 at	 the	 core	 of	 the	 earliest	 changes	 involved	 in	 dementia.43	 However,	
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        Model fA Md
All	dementia	(n=101)	 	 	 	 model		I 0.65 (0.53;0.80) 1.77 (1.43;2.17)
	 	 	 	 	 	 	 	 model		II 0.65 (0.52;0.80) 1.79 (1.44;2.23)
AD	(n=83)	 	 	 	 	 	 model		I 0.70 (0.55;0.88) 1.71 (1.35;2.16)
	 	 	 	 	 	 	 	 model		II 0.69 (0.54;0.88) 1.76 (1.38;2.24)
Censoring	for	stroke	(n=98)		 	 model		I 0.65 (0.53;0.80) 1.75 (1.41;2.16)
	 	 	 	 	 	 	 	 model		II 0.64 (0.52;0.80) 1.76 (1.42;2.20)
Exclusion	cortical	infarcts	(n=97)	 model		I 0.63 (0.51;0.78) 1.75 (1.41;2.17)








Abbrevations: FA: fractional anisotropy, MD; mean diffusivity, BMI: Body Mass Index, CES-D: Center for 













(n=4374/88) (n=4305/74 ) (n=4224/56) (n=4131/41) (n=3872/25)
FA 0.63 (0.50;0.78) 0.70 (0.54;0.89) 0.64 (0.48;0.86) 0.73	(0.52;1.03) 0.60 (0.39;0.91)










G-factor 0.01	(-0.01;0.04) -0.03 (-0.06;-0.001)
Immediate	memory -0.007	(-0.04;0.03) -0.01	(-0.06;0.03)
Delayed	memory 0.002	(-0.03;0.03) -0.02	(-0.06;0.02)
Stroop	1 0.04 (0.01;0.07)* -0.06 (-0.09;-0.02)*
Stroop	2 0.03 (0.003;0.05) -0.02	(-0.05;-0.01)
Stroop	3 0.04 (0.009;0.06) -0.08 (-0.12;-0.04)*
Letter-Digit	Substitution	Task 0.005	(-0.02;0.03) -0.004	(-0.04;0.02)
Word	Fluency	Test 0.03 (0.002;0.06) -0.06 (-0.10;-0.02)*
Purdue	Pegboard 0.03 (0.002;0.06) -0.03	(-0.06;0.009)
Data	are	presented	as	mean	difference	in	Z-score	(95%	CI)	per	standard	deviation	increase	of	FA	and	MD.	
Results	in	bold	were	significant	at	p<0.05	and	those	that	were	starred	*	at	p<0.008.




Abbreviations: FA: fractional anisotropy, MD; mean diffusivity, BMI: Body Mass Index, CES-D score: Center 
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Progressive	 sensorineural	 hearing	 impairment	 is	 a	 common	 feature	 of	 aging.	 It	 is	
characterized	 by	 a	 gradual	 decline	 of	 hearing	 thresholds	 and	 worse	 understanding	
of	 speech,	which	 seriously	affects	 the	quality	of	 life.1	Although	cochlear	damage	 is	
generally	believed	to	cause	age-related	hearing	impairment,	there	is	strong	evidence	
that	 age-related	 hearing	 impairment	 also	 has	 a	 central	 component	 in	 its	 pathogen-
esis.2	Moreover,	 age-related	 hearing	 impairment	 seems	 to	 interact	 with	 the	 general	




cardiovascular	 damage.4	There	 are	 also	2	 alternative	hypotheses.	The	 “information-
degradation	 hypothesis”	 describes	 an	 indirect	 effect	 between	 hearing	 and	 the	 brain	
through	a	shift	of	cognitive	functions.	The	“sensory-deprivation	hypothesis”	describes	
a	direct	causal	relationship	in	which	worse	hearing	acuity	leads	to	brain	alterations.5 
Previous	 studies	 using	 brain	 imaging	 have	 demonstrated	 that	 hearing	 acuity	 in	 the	
aged	and	middle-aged	population	relates	to	morphological	brain	changes	(e.g.,	gray-	or	
white-matter	atrophy.6,7,8,9		In	a	previous	study	in	almost	3000	people	conducted	by	our	







connections14,	 especially	 in	 the	 left	 hemisphere	 due	 to	 functional	 lateralization.	 In	
recent	years,	diffusion	tensor	imaging	(DTI)	has	increasingly	been	used	to	study	brain	
white-matter	tracts.	This	technique	allows	for	estimation	of	the	microscopic	organiza-






































To	address	 the	above	 issues,	we	conducted	a	 large	population-based	 study	on	com-
munity-dwelling	older	adults.	Our	primary	objective	was	 to	analyze	 the	association	
between	the	global	and	tract-specific	white-matter	microstructure	and	hearing	acuity	
using	DTI.	Second,	we	aimed	 to	 investigate	 the	effect	of	 aging	on	 this	possible	as-
sociation,	because	aging	is	associated	with	both	white	matter	degeneration	and	worse	
hearing	 acuity.	 In	 the	 analyses,	we	used	both	 auditory	 thresholds	 (low,	 speech,	 and	
high	frequencies)	and	the	ability	for	speech	recognition	in	noise,	and	we	accounted	for	
possible	 cognitive	 and	 cardiovascular	 covariates.	We	 hypothesized	 that	 participants	
with	worse	hearing	acuity	would	have	a	lower	FA	and	higher	MD,	which	corresponds	
with	poorer	white-matter	microstructure	in	the	tracts.	We	assumed	different	outcomes	




























MrI acquisition and processing
Multisequence	MRI	 imaging	was	performed	 in	a	1.5	Tesla	MRI	scanner	 (GE	Signa	
Excite).	The	MRI	protocol	included	a	T1-weighted	image	(T1w,	repetition	time	13.8	












scans	 for	 each	 participant	were	 spatially	 coregistered	 using	 rigid	 registration.	After	
brain	masking	 and	 nonuniformity	 correction	 scans	were	 segmented	 in	 gray	matter,	
white	matter,	cerebrospinal	fluid,	and	background	tissue	using	a	supervised	approach	









corrected	diffusion	data	were	also	used	 to	estimate	 the	probabilistic	model	 required	
for	 ProbTrackx	 tractography.29	 We	 performed	 tractography	 in	 native	 space,	 using	
standard	space	seed,	target,	stop,	and	exclusion	masks	as	described	previously.30 The	
probabilistic	 tractography	 algorithm	was	 run	with	 default	 settings	 (step	 length	 0.5,	





pearing	white	matter.	FA	is	 the	degree	of	anisotropy	and	 is	given	as	a	 ratio	 ranging	
from	0	(isotropic	or	non-directional)	to	1	(unidirectional).	MD	is	expressed	in	square	




projection	 tracts	 (corticospinal	 tract,	 anterior	 thalamic	 radiation,	 superior	 thalamic	
radiation,	 and	posterior	 thalamic	 radiation),	 association	 tracts	 (superior	 longitudinal	
fasciculus,	 inferior	 longitudinal	 fasciculus,	 inferior	 fronto-occipital	 fasciculus,	 and	
uncinated	fasciculus),	limbic	system	tracts	(cingulate	gyrus	part	of	cingulum,	parahip-
pocampal	 part	 of	 cingulum,	 and	 fornix),	 and	 callosal	 tracts	 (forceps	major,	 forceps	
minor)	 in	 the	 left	 and	 right	hemisphere.32	Due	 to	 tractography	 failures	or	 (visually)	
rejected	segmentations,	tract-specific	measurements	were	missing	for	on	average	6.9	
participants	 (ranging	 from	0	 to	61	participants)	per	 tract.	We	obtained	 tract-specific	
diffusion	measures	(mean	FA	and	mean	MD	per	 tract.32	We	standardized	global	and	



















All	 audiometry	 was	 performed	 in	 a	 soundproof	 booth	 by	 a	 single	 qualified	 health	
professional.	A	 clinical	 audiometer	 (Decos	 audiology	workstation,	 version	 210.2.6,	
with	AudioNigma	interface),	TDH-39P	earphones	and	B71	bone	conductor	were	used.	
Pure-tone	audiometry	thresholds	were	measured	according	to	the	International	Orga-
nization	 for	Standardization	8253-1	 (International	Organization	 for	Standardization,	
2010).	Air	conduction	(0.25,	0.50,	1,	2,	4,	and	8	kHz)	and	bone	conduction	(only	2	
frequencies	due	to	limited	time:	0.5	and	4	kHz)	were	tested	for	both	the	ears.	Masking	
was	done	according	 to	 the	method	of	Hood.36	Bone	conduction	 thresholds	at	4	kHz	
were	compensated	with	+10	decibel	(dB)	afterward.38	We	determined	the	best	hearing	
ear	 by	 calculating	 the	 average	 threshold	 over	 all	 frequencies.	 If	 both	 the	 ears	were	
equal,	right	or	left	was	alternately	chosen.	Of	the	best	hearing	ear,	we	then	determined	
the	low	(average	of	0.25,	0.50	and	1	kHz),	speech	(average	of	0.50,	1,	2	and	4	kHz),	
and	 high	 frequency	 hearing	 thresholds	 (average	 of	 2,	 4	 and	 8	 kHz).	We	 excluded	
















ment	 of	 the	 study,	 or	 by	 recurrent	 physical	 examination	 and	 blood	 sampling	 at	 the	
study	center.	Education	was	qualified	as	having	completed	primary	level,	secondary	
















MD	were	 regarded	as	 independent	variables,	and	pure-tone	 thresholds	and	score	on	




















examined	 the	 presence	 of	 multicollinearity	 and	 found	 no	 variance	 inflation	 factor	
larger	than	4.	For	the	VBA	linear	regression	models	were	fitted	with	voxel	values	of	
FA	and	MD	measures	as	dependent	variables	and	pure-tone	thresholds	and	score	on	
the	DIN-test	 as	 independent	 variables.	 Furthermore,	we	 corrected	 the	VBA	models	





distribution	 to	 compute	 the	 family-wise	 error	 p-value	 threshold,	 which	was	 1.21	 x	
10-7 for	FA	and	1.23	x	10-7	for	MD.41	To	map	the	significant	voxels	to	the	tract	loca-
tion,	we	created	a	tract	study-specific	atlas.	Subject-specific	tract	segmentations32	were	




Missing	 data	 were	 minimal	 (0.4%	 of	 total	 data)	 and	 were	 imputed	 in	 SPSS	 using	










































figure 1. Mean	hearing	thresholds	on	the	pure-tone	audiogram	of	all	participants 
(N	=	2,562).  




















The	association	between	global	DTI	measures	 and	hearing	acuity	 is	 presented	 in	
Table	 2.	 To	 compare	 the	 effect	 of	 the	 DTI	 measures,	 the	 betas	 of	 the	 most	
important	covariates	(age,	gender,	and	MMSE-score)	are	also	shown.	A	lower	FA	
was	 significantly	 associated	 with	 worse	 hearing	 acuity,	 that	 is,	 higher	 hearing	





DIN-test,	 95%	 CI	 0.09;	 0.37).	 A	 higher	 MD	 was	 significantly	 associated	 with	
worse	 hearing	 acuity	 on	 the	 pure-tone	 audiogram	 for	 the	 speech	 and	 higher	
frequencies	 in	 model	 2.	 MD	 and	 the	 outcomes	 of	 the	 DIN-test	 were	 not	
significantly	associated.	Subsequently,	we	analyzed	the	association	between	tract-
specific	DTI	measurements	and	hearing	acuity	(Supplemental	Tables	1	and	2).	The	
association	 of	 a	 lower	 FA	 and	 worse	 hearing	 acuity	 was	 primarily	 found	 in	 the	
association	tracts:	superior	longitudinal	fasciculus,	inferior	longitudinal	fasciculus,	
inferior	 fronto-occipital	 fasciculus,	 and	 uncinate	 fasciculus	 (Table	 3).	 However,	
only	the	association	between	the	superior	longitudinal	fasciculus	and	worse	hearing	
on	 the	 pure-tone	 audiogram	 and	 the	 association	 between	 the	 uncinate	 fasciculus	


















tract-specific	DTI	measurements	and	hearing	acuity	(Supplemental tables 1 and 2).	
The	association	of	a	 lower	FA	and	worse	hearing	acuity	was	primarily	 found	 in	 the	






When	 differentiating	 the	 tracts	 between	 left	 and	 right	 hemisphere	 (Supplemental 
























ALL LOW SPEECH HIGH
↓	in	FA
(model	1)
 0.69 (0.24; 1.14)
 0.002
 0.42 (0.00; 0.84)
 0.049








 0.92 (0.86; 0.99)
 0.000
 0.53 (0.47; 0.60)
 0.000
 0.81 (0.74; 0.89)
 0.000








 2.29 (1.27; 3.30)
 0.000






 0.86 (0.41; 1.30)
 0.000
 0.56 (0.14; 0.97)
 0.008








 0.90 (0.83; 0.98)
 0.000
 0.51 (0.45; 0.58)
 0.000
 0.80 (0.72; 0.88)
 0.000








 1.85 (0.80; 2.90) 
 0.001






























 0.92 (0.85; 0.99)
 0.000
 0.53 (0.47; 0.60)
 0.000
 0.81 (0.74; 0.89)
 0.000








 2.28 (1.26; 3.30)
 0.000










 0.57 (0.02; 1.12) 
 0.042






 0.90 (0.82; 0.97)
 0.000 
 0.51 (0.44; 0.58)
 0.000
 0.80 (0.72; 0.88)
 0.000








 1.87 (0.81; 2.92)
 0.001

































global	DTI	measurements	 and	 pure-tone	 audiogram	were	 significant	 in	 the	middle-
aged	group,	but	not	 in	the	older	group.	On	the	other	hand,	 the	associations	between	
global	DTI	measurements	and	the	DIN-test	were	significant	in	the	older	group,	but	not	





























































































































Our	objective	was	 to	 investigate	 the	 association	between	brain	white-matter	micro-








































against	 the	 “common	 cause	 hypothesis”.	Otherwise,	we	would	 have	 expected	more	















a	 different	 role	 in	 age-related	 diseases.	We	 found	 that	 primarily	 association	 tracts,	
among	these	the	superior	longitudinal	fasciculus	and	uncinate	fasciculus,	were	related	
to	hearing	acuity.	Association	tracts	connect	the	different	cortical	regions	of	the	same	
hemisphere	 and	 are	 typically	 located	 in	watershed	 areas,	 implying	 that	 their	 blood	
supply	relies	on	small	and	deep	lenticulostriate	arteries.	Association	tracts	may	there-
fore	be	more	vulnerable	 to	 insults	and	vascular	damage.42	The	superior	 longitudinal	





cessing	and	memory,	 including	 linguistic-related	 tasks	 such	as	naming	people45,	 se-
mantic	processing	such	as	mnemonic	associations46	and	better	overall	language	devel-








not	find	an	association	with	 the	uncinate	 fasciculus.	They	did	not	perform	a	 test	on	




effect	 of	 aging	 on	 the	 association	 between	white-matter	microstructure	 and	 hearing	
acuity.	We	hypothesized	a	possible	progression	of	white	matter	damage	in	worse	hear-
ing	acuity	with	age.	Besides	correcting	for	age	as	a	possible	confounder	in	multivari-































areas.	An	 explanation	 for	finding	different	 results	with	 the	 tract-specific	 and	voxel-
based	analysis	may	be	that	due	to	multiple	comparisons	corrections,	the	threshold	for	






we	 could	 reconstruct	 the	 tracts	 of	 our	 interest	 accurately.	Unfortunately,	 it	was	 not	
possible	to	differentiate	in	our	specific-tract	data	for	subcomponents,	for	example,	the	





associated	with	worse	 hearing	 acuity,	 specifically	 in	 the	 right	 superior	 longitudinal	
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resulted	 in	 4294	participants	 for	 both	 global	 and	 tract-specific	 analyses	 (age	 range:	
45.7-100.0).
Standard Protocol Approvals, registrations, and Patient Consents
The	Rotterdam	Study	has	been	approved	by	the	medical	ethics	committee	according	
to	 the	 Population	 Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	Health,	
Welfare	and	Sports	of	the	Netherlands.	A	written	informed	consent	was	obtained	from	
all	participants.15
MrI acquisition, processing and inspection
Brain	MRI	scanning	was	performed	on	a	1.5T	MRI	scanner	(GE	Signa	Excite).	Scan	
protocol	 and	 sequence	 details	 are	 described	 extensively	 elsewhere.16	 For	 the	 diffu-
sion	scan,	a	single	shot,	diffusion	weighted	spin	echo	echo-planar	imaging	sequence	
was	 performed	 (maximum	 b-value	was	 1000	 s/mm2	 in	 25	 non-collinear	 directions,	
three	volumes	were	acquired	without	diffusion	weighting	(b-value	=	0	s/mm2)).16	The	
T1-weighted,	 proton,	 density-weighted	 and	 the	 fluid-attenuated	 inversion	 recovery	
scans	 were	 used	 for	 automated	 segmentation	 of	 grey	 matter,	 white	 matter,	 white	
matter	 hyperintensities	 (WMH),	which	was	 extended	with	 a	 post-processing	WMH	






























linkage	with	General	Practitioner	 (GP)	files.	 In	addition,	central	 registry	of	 the	mu-
nicipality	 in	Rotterdam	was	 checked	bimonthly	 for	 information	on	vital	 status.	 For	
participants	moved	outside	the	research	area,	the	GPs	were	the	primary	source	of	infor-
mation,	complemented	by	the	municipality	records	in	the	place	of	residence.	This	also	




I99	and	death	due	 to	other	 reasons	was	 recorded	as	non-cardiovascular	mortality.	A	
consensus	panel,	led	by	a	physician	with	expertise	in	cardiovascular	disease,	decided	





visit	 using	 a	 random-zero	 sphygmomanometer.	 Total	 and	 high	 density	 lipoprotein	
(HDL)	cholesterol	levels	were	determined	using	an	automated	enzymatic	method.	In-
formation	on	smoking	and	antihypertensive	and	lipid	lowering	medication	was	based	
















factors	 including	 systolic	 blood	 pressure,	 diastolic	 blood	 pressure,	 antihypertensive	
medication,	 total	 and	HDL	cholesterol,	 lipid-lowering	medication,	 smoking,	history	




and	 presence	 of	 lacunar	 infarcts.	 In	 both	 the	 global	 and	 tract-specific	 analysis	 we	
adjusted	for	WMH	volume	to	control	for	possible	partial	volume	effects	and	to	single	
out	 real	microstructural	 changes.7	Model	 four	was	 adjusted	 for	 all	 covariates	 from	
first,	 second	 and	 third	 models.	 Tract-specific	 analyses	 were	 performed	 with	 model	
three.21	Since	the	cerebellum	could	not	always	be	fully	incorporated	in	the	diffusion	
scan	leading	to	a	varying	coverage	of	the	brainstem	tracts	(mainly	medial	lemniscus),	



























participants	 died.	 For	 cause-specific	 mortality,	 during	 the	 median	 [interquartile	 range]	
follow-up	time	of	4.6	[3.3-5.7]	years,	31	(0.7%)	individuals	died	of	cardiovascular	causes	
table 1. Baseline	characteristics




































                         White	matter	microstructure	and	mortality    
221 
During	the	median	[interquartile	range]	follow-up	time	of	5.4	[3.6-5.9]	years,	216	
(5%)	 participants	 died.	 For	 cause-specific	 mortality,	 during	 the	 median	
[interquartile	 range]	 follow-up	 time	 of	 4.6	 [3.3-5.7]	 years,	 31	 (0.7%)	 individuals	
died	 of	 cardiovascular	 causes	 and	 102	 (2.4%)	 participants	 died	 from	 non-
cardiovascular	 causes.	 All-cause	mortality	 rates	 in	 participants	 with	 low,	middle	
and	high	tertiles	of	FA	and	MD	are	shown	in	figure 1.  
 
 
In	 model	 I,	 adjusted	 for	 age	 and	 sex,	 decrease	 in	 FA	 and	 increase	 in	 MD	 was	
associated	 with	 higher	 hazard	 of	 all-cause	 mortality.	 Adjustments	 for	
cardiovascular	 risk	factors,	macrostructural	MRI	changes	and	presence	of	lacunar	
infarcts	and	microbleeds	attenuated	the	associations	minimally	(table 2).  
 




was	 associated	 with	 1.84-fold	 increased	 hazard	 of	 cardiovascular	 mortality	
(95%CI:	 1.26,	 2.68).	 After	 adjustments	 for	 cardiovascular	 risk	 factors	 and	
macrostructural	MRI	changes	and	presence	of	lacunar	infarcts	and	microbleeds,	the	
associations	attenuated	and	were	no	longer	significant	(p=	0.207).	Higher	MD	was	
associated	 with	 increased	 hazard	 of	 non-cardiovascular	 mortality	 (HR:	 1.31,	
95%CI:	 1.04,	 1.65),	 but	 the	 association	 was	 no	 longer	 significant	 after	 further 












Hazard ratio* (95% CI)



































Cardiovascular mortality Non-cardiovascular mortality
Hazard ratio* (95% CI)
N=4294 (31) p value
Hazard ratio* (95% CI)
N=4294 (102) p value
fractional anisotropy 
			Model	I 1.99	(1.44,	2.77) <0.001 1.19	(0.98,	1.44) 0.079
			Model	II 1.81	(1.28,	2.57) 0.001 1.13	(0.93,	1.38) 0.206
			Model	III 1.62	(1.12,	2.34) 0.010 1.07	(0.87,	1.33) 0.513
			Model	IV 1.53	(1.04,	2.24) 0.029 1.04	(0.84,	1.28) 0.735
Mean diffusivity
			Model	I 1.84	(1.26,	2.68) 0.001 1.31	(1.04,	1.65) 0.021
			Model	II 1.66	(1.10,	2.49) 0.015 1.22	(0.97,	1.54) 0.085
			Model	III 1.48	(0.96,	2.30) 0.077 1.12	(0.86,	1.46) 0.381
			Model	IV 1.34	(0.85,	2.13) 0.207 1.07	(0.82,	1.38) 0.620















In	 the	 tract-specific	 analyses,	we	observed	 that	 for	 all	 tracts,	MD	was	more	promi-
nently	related	to	mortality	than	FA.	For	FA,	after	correcting	for	multiple	testing,	lower	












Medial	lemniscus	a 1.03	(1.22,	0.87)  1.21 (1.06, 1.37)*
Projection tracts
Corticospinal	tract 1.06	(1.22,	0.93)  1.29 (1.11, 1.49)*
Anterior	thalamic	radiation 1.05	(1.23,	0.89) 1.17 (1.00, 1.37)
Superior	thalamic	radiation 1.06	(1.22,	0.93) 1.21 (1.05, 1.38)
Posterior	thalamic	radiation 1.19	(1.43,	1.00) 1.10	(0.95,	1.27)
Association tracts
Superior	longitudinal	fasciculus 1.20 (1.41, 1.03)  1.28 (1.13, 1.46)*
Inferior	longitudinal	fasciculus 1.09	(1.30,	0.92)  1.28 (1.09, 1.49)*
Inferior	fronto-occipital	fasciculus 1.25 (1.49, 1.04) 1.24	(1.05,	1.45)
Uncinate	fasciculus 1.27 (1.49, 1.06)  1.35 (1.15, 1.57)*
Limbic system tracts 
Cingulate	gyrus	part	of	cingulum 1.09	(1.28,	0.93)  1.27 ( 1.10, 1.47)*
Parahippocampal	part	of	cingulum 1.14	(1.30,	0.97) 1.00	(0.91,	1.10)
Callosal tracts
Forceps	major 1.28 (1.52, 1.06) 1.08	(0.96,	1.23)










We	 showed	 that	 among	 community-dwelling	 individuals,	 lower	microstructural	 in-
tegrity	 of	 cerebral	white	matter	 is	 related	 to	 an	 increased	mortality,	 independent	 of	
cardiovascular	 risk	 factors,	macrostructural	MRI	changes	 (white	matter	volume	and	
the	log	transformed	volume	of	white	matter	hyperintensities),	and	presence	of	lacunar	




axons	 that	 transmit	 signals	mostly	 between	 various	 regions	 of	 the	 brain	 and	 spinal	
cord.2	White	matter	accounts	for	nearly	half	of	the	brain	volume	and	its	microstructural	
integrity	 is	 crucial	 for	 normal	 brain	 function.7	White	matter	 damage	 represented	 as	








We	observed	 that	poorer	white	matter	microstructural	 integrity	was	 associated	with	
higher	 all-cause,	 cardiovascular,	 and	 non-cardiovascular	mortality,	 but	most	 promi-
nently	with	cardiovascular	mortality.	A	possible	explanation	for	this	observation	could	
be	 that	 white	 matter	 is	 more	 prone	 to	 vascular	 insults.28,29	 Shared	 cardiovascular	
risk	 factors	 such	as	hypertension	and	diabetes	might	play	a	 role	 in	 this	association.	
Adjusting	 for	 cardiovascular	 risk	 factors	 attenuated	 the	 associations;	 but	 the	 find-
ings	 persisted.	This	might	 indicate	 that	 at	 least	 part	 of	 the	 association	 is	 driven	 by	




the	analyses,	we	cannot	 exclude	 the	possibility	 that	 impairment	 in	 the	white	matter	
integrity	could	be	related	to	(preclinical)	neurodegenerative	processes,	in	particular	in	
the	association	tracts.
Available	 literature	 suggests	 that	 damage	 to	 cerebral	white	matter	 is	 not	 only	 asso-





may	 therefore	 influence	 a	 variety	 of	 functions	 throughout	 the	 body	 that	may	 result	
in	a	higher	 risk	of	mortality,	 also	due	 to	causes	other	 than	neurological	diseases.6,30 










that	 FA	 is	 dominated	 by	 tract	 coherence	 and	 axonal	 loss,	 and	MD	 by	 (volume	 of)	
interstitial	or	extracellular	fluid.31,32	Besides	a	biological	difference,	MD	seems	to	be	a	
more	sensitive	diffusion-MRI	measure	in	regions	with	crossing	tracts.33
The	 associations	 found	with	MD	were	widespread	 in	 the	 brain,	 but	more	 apparent	
to	 the	 association	 tracts,	 which	 may	 be	 explained	 by	 the	 variable	 susceptibility	 to	














particularly	 for	FA.	 In	 contrast	 to	FA,	MD	seems	 to	 be	 a	more	 reliable	measure	 in	










pendent	 of	 several	 cardiovascular	 risk	 factors,	 roles	 of	 other	 potential	 confounders	
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Age,	years 63.6	(11.0) 68.0	(12.2) <0.001
Men	 1906	(44.4) 470	(41.4) 0.128
Systolic	blood	pressure,	mmHg 139.0	(21.5) 144.6	(24.5) 0.017
Diastolic	blood	pressure,	mmHg 83.1	(10.8) 83.6	(11.8) 0.548
Antihypertensive	medication 1463	(34.1) 555	(48.9) 0.005
Total	cholesterol,	mmol/l 5.5	(1.0) 5.3	(1.1) <0.001
HDL	cholesterol,	mmol/l 1.4	(0.4) 1.4	(0.4) 0.009
Lipid-lowering	medication 1014	(23.6) 368	(33.2) <0.001
Smoking	
			Current 878	(20.4) 236	(21.3) <0.001
			Former 2060	(48.0) 545	(48.0)
History	of	coronary	heart	disease 256	(6.0) 105	(9.2) 0.100
Diabetes	mellitus 393	(9.2) 145	(12.8) 0.009




Hazard ratio* (95% CI)




















table e-3. The	association	of	white	matter	microstructural	 integrity	and	cardiovascular	mortality	excluding	
death	from	stroke
Cardiovascular mortality
Hazard ratio* (95% CI)
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figure e-2.  
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General	 cognitive	 function	 represents	 the	 ability	 to	 perform	 tasks	 across	 different	
cognitive	domains.	The	development	of	the	nervous	system	shapes	an	important	part	
of	the	inter-individual	variation	in	general	cognitive	function,	with	neurodegenerative	
processes	 increasingly	contributing	 later	 in	 life.1,2	The	developmental	component	of	








elucidated	 by	 the	 identification	 of	 genetic	 variants	 in	 148	 independent	 loci	 (Davies	



































with	 a	 call	 rate	 below	97.5%	were	 removed,	 as	well	 as	 gender	mismatches,	 excess	
autosomal	heterozygosity,	duplicates	or	family	relations,	ethnic	outliers,	variants	with	
call	 rates	 lower	 than	 95.0%,	 failing	 missingness	 test,	 Hardy-Weinberg	 equilibrium	







an	 r2<0.30	were	 excluded	 (N=7	 and	N=1,	 respectively).	 For	 the	 remaining	 genetic	
variants	 (N=170),	 the	 allele	 dosage	was	multiplied	 by	 the	 reported	 effect	 estimate.	
Subsequently,	 the	 weighted	 effects	 of	 all	 variants	 were	 added	 up	 and	 the	 resulting	
polygenic	scores	were	standardized	into	Z-scores.
Furthermore,	we	 aimed	 to	 differentiate	 the	 reserve	 component	 of	 general	 cognitive	
function	 from	 the	 degenerative	 effects.	 Therefore,	 we	 calculated	 additional	 PGSs	
where	variants	associated	with	educational	attainment	and	 intracranial	volume	were	
removed	using	multiple	p-value	 thresholds.	For	each	variant,	we	used	 the	 lowest	p-
value	threshold	for	either	educational	attainment	or	intracranial	volume.	The	p-values	




The	different	p-value	 thresholds	 for	 the	association	with	educational	attainment	and	
intracranial	 volume,	with	 the	 corresponding	 number	 of	 variants	 that	 remained,	 and	










tion	Task	 (LDST),	 the	Word	Fluency	Test	 (using	animal	categories)	and	 the	Purdue	
pegboard	(PPB)	task	for	the	left	hand,	right	hand	and	both	hands.2,11-14	A	measure	of	











was	measured	 using	 the	Dutch	 version	 of	 the	 Instrumental	Activities	 of	Daily	Liv-




Assessment of clinical outcomes
The	assessment	of	dementia,	parkinsonism	(including	PD)	and	stroke	were	previously	






for	 dementia,	 parkinsonism	 and	 stroke	 through	 automated	 linkage	 of	 the	 study	 da-





MrI acquisition and processing
We	performed	a	multi-sequence	brain	MRI	scan	on	a	1.5	tesla	research	dedicated	MRI	
scanner	 (GE	 Signa	 Excite).	 Imaging	 details	 are	 provided	 elsewhere.26	 In	 short,	 the	
scan	 protocol	 included	 a	T1-weighted	 image,	 a	T2-weighted	 fluid-attenuated	 inver-
sion	 recovery	 (FLAIR)	 sequence,	 a	proton	density	weighted	 image	and	a	 spin	echo	
echo	planar	diffusion	weighted	 image	for	 the	diffusion-MRI.	Scans	were	segmented	
into	 grey	matter,	white	matter,	white	matter	 lesion	 volume,	 cerebrospinal	 fluid	 and	














































Cognitive performance and daily functioning




































































Age, years 64.0±9.1 64.0 
(11.0)































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   












































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   



























































































































































































































































































































































































































































































































































































































































































































































figure 2, panel B	shows	that	the	PGS	was	associated	with	less	decline	in	cognitive	
function	(βΔG-factor=0.027,	p=1.5x10
-3).	The	PGS	was	also	associated	with	less	decline	
in	BADL,	 although	 this	was	 not	 significant	 after	multiple	 comparison	 adjustments.	
Removing	variants	associated	with	educational	attainment	and	intracranial	volume	re-
sulted	in	an	attenuation	of	the	effects.	In	the	single-variant	analysis,	no	variant	reached	







threshold	 (hazard	 ratio	 1.06,	 p=0.040),	 although	 this	 did	 not	 survive	 correction	 for	
multiple	testing.
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global	white	matter	microstructural	 integrity.	We	 found	 that	 a	 higher	PGS	was	 sig-
nificantly	 related	 to	 a	 larger	 intracranial	 volume	 (b=0.05,	 p=7.5x10-4),	 but	 not	with	
the	other	volumetric	and	global	white	matter	microstructural	integrity	(figure 4).	At	
a	 nominal	 significance	 level,	 a	 higher	 PGS	was	 associated	with	 a	 higher	 FA	 in	 the	
medial	lemniscus,	and	a	lower	MD	in	the	inferior-fronto-occipital	fasciculus	and	the	







for	 age	 and	 sex.	 Two	 polygenic	 scores	 are	 presented,	 one	 including	 all	 independent	












reserve	 component	 of	 cognition,	 which	 consists	 of cognitive	 reserve	 (educational	 attainment)	 and	
brain	reserve	(intracranial	volume).	Also,	the	five top	genetic	variants	for	the	association	with	these	
brain	 imaging	markers	 are	 presented.	 Positive	 associations	 depicted	 in	 blue	 correspond	 to	 a	 larger	
volume	 or	 a	 better	 white	 matter	 microstructural	 integrity.	 Larger	 blocks	 indicate	 higher	 t-values.	
Significance	 levels	are	 indicated	by	asterisks:	*p<0.05,	nominally	significant;	**p<0.0101,	adjusted	















lead	variants,	 and	one	only	 including	variants	with	 a	p>0.05	 for	 the	 association	with	
the	 reserve	 component	 of	 cognition,	which	 consists	 of	 cognitive	 reserve	 (educational	
attainment)	 and	 brain	 reserve	 (intracranial	 volume).	 Larger	 blocks	 indicate	 higher	 t-
values.	Higher	scores	indicate	better	performance,	except	for	the	Stroop	test,	the	Basic	
Activities	 of	 Daily	 Living	 and	 Instrumental	Activities	 of	 Daily	 Living.	 Significance	
levels	are	 indicated	by	asterisks:	*p<0.05,	nominally	significant;	**p<0.0038	(figure 
2, panel A)	or	p<0.0040	(figure 2, panel B),	adjusted	for	the	number	of	independent	
traits	as	calculated	 through	10000	permutations;	***p<2.2	x	10-5	 (figure 2, panel A;	




on	 recently	 identified	genetic	variants	 for	global	cognition	was	associated	with	bet-









sectionally	 and	 longitudinally.	This	 indicates	 that	 the	 genetic	 variants	 can	 partially	





























ferent	 analyses	were	 attenuated,	 supporting	 the	 suggestion	 that	 the	 genetic	 variants	
mainly	represent	the	reserve	component	of	cognitive	performance.	However,	removing	
genetic	variants	associated	with	the	reserve	component	may	also	eliminate	degenera-




an	elderly	population	since	neurodegeneration	mainly	occurs	 later	 in	 life.	However,	
longitudinal	measurements	such	as	those	in	the	present	study	are	only	available	in	a	





to	consider	 limitations.	 It	should	be	noted	 that	 the	Rotterdam	Study	was	part	of	 the	
discovery	cohort	for	 the	general	cognitive	function	GWAS	(Davies	et	al).	However,	
since	this	was	only	a	small	proportion	of	the	total	sample	size	(2.0%),	we	do	not	expect	




In	 conclusion,	we	 found	 that	 the	PGS	of	 general	 cognitive	 function	was	 associated	
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the	 5%	 of	 participants	 with	 the	 largest	 cognitive	 decline	 per	 year.	We	 trained	DSI	
to	predict	occurrence	of	significant	global	cognitive	decline	using	a	 large	variety	of	








Conclusion	The	best	 performance	 in	 the	prediction	of	 global	 cognitive	decline	 in	
the	 general	 population	by	DSI	was	 obtained	using	only	 age	 as	 input	 feature.	Other	
features	showed	potential,	but	did	not	improve	prediction.	Future	studies	should	evalu-






































We	 included	 participants	 from	 three	 independent	 cohorts	 within	 the	 Rotterdam	






cording	 to	 the	Population	Study	Act	Rotterdam	Study,	 executed	 by	 the	Ministry	 of	
Health,Welfare	and	Sports	of	the	Netherlands.	Written	informed	consent	was	obtained	
from	 all	 participants.14 We	 used	 data	 from	 RS	 cohorts	 I,	 II	 and	 III,	 of	 which	 each	
consists	of	multiple	 subcohorts.	 In	 this	 study	a	 subcohort	of	RS	cohort	 I,	 II	 and	 III	
were	 used,	 to	 which	we	 refer	 as	 sI,	 sII	 and	 sIII,	 respectively.	 Baseline	 features	 of	


















DSI	 classifier	 is	 composed	of	 the	 components:	fitness	 and	 relevance.3 Let N	 be	 the	
total	number	of	negatives,	P	the	total	number	of	positives,	FN(x)	the	number	of	false	













disease State Index 
Prediction was performed with DSI [3]. This classifier derives an index indicating the disease state of the 
partici- pant under investigation based on the available features of that participant. DSI has two major 
advantages: 1) it can	cope	with	missing	data	and	2)	it	gives	an	interpretable	result	because	DSI	also	provides	
a	decision	tree	that	can	be	quite	well explained. 
 
DSI classifier is composed of the components: fitness and relevance [3]. Let N be the total number of 
negatives, P the total number of positives, FN(x) the number of false negatives, and FP(x) the number of 




  FNRi(x) =  FNi(x)   
(1) 
FNRi(x) + FPRi(x) FNi(x)	+ P FPi(x) 
 
where	FNR(x)	= FN(x)/P is	 the	 false	negative	 rate	and	FPR(x)	= FP(x)/N is	 the	 false	positive	 rate	 in	 the	
training data when the feature value x is used as the classification cut-off. The fitness automatically accounts 
for the	 imbalance	 in	 class	 size	 making	 implicitly	 both	 classes	 equal	 in	 size,	 as	 the	 fraction	 P/N in	 the	
denominator	 scales	 the	 negative	 class	 (related	 to	FP(x))	 to	 correspond	 the	 size	 of	 the	 positive	 class.	 The	
fitness	 function	 is	 a	 classifier	 where the values < 0.5 imply negative class and > 0.5 positive class. The 
relevance of each feature is estimated by: 
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Because	 of	 that,	DSI	 can	 tolerate	missing	 data.	 Features	 can	 be	 grouped	 in	 a	 hier-























intensity	 thresholding.16	 We	 obtained	 (sub)cortical struc- ture volumes,	 cortical 
thickness,	and	curvature	of	 the	cortex	and	hippocampal	volume	using	the	publicly	




















gradient-recalled	echo	was	used	 to	 image	cerebral microbleeds.	Microbleeds	were	





Probabilistic	 tractography	 was	 used	 to	 segment	 15	 different	 white	 matter	 tracts	 in	






We	used	 the	mean	of	 two	measurements	 in	 the	analyses.	 Information	on	 the	use	of	
antihypertensive medication	was	obtained	by	using	questionnaires	and	by	checking	
the	medication	 cabinets	 of	 the	 participants.	Hypertension	was	 defined	 as	 a	 systolic	
blood	pressure	>140	mmHg	or	a	diastolic	blood	pressure
>90	mmHg	or	the	use	of	anti-hypertensive	medication	at	baseline.	Serum total cho-






















We	 included	 the	 following	 objective memory	 and	 non-memory	 cognitive	 tests:	
15-word Learning test imme- diate	 and	delayed recall,28 Stroop tests	 (reading,	
color-naming	 and	 interference),29,	 30 the Letter-digit Substitution task,31 word 
fluency test,32	 and	 the	Purdue Pegboard test.33 Subjective cognitive complaints 
were	 evaluated	 by	 interview.	This	 interview	 included	 three	 questions	 on	mem-	 ory	
(difficulty	remembering,	forgetting	what	one	had	planned	to	do,	and	difficulty	finding	
words),	 and	 three	 questions	 on	 everyday	 functioning	 (difficulty	managing	 finances,	
problems	using	a	telephone,	and	difficulty	getting	dressed).34






participant,	 the	 delta	 g-factor	 was	 divided	 by	 the	 follow-up	 time	 to	 obtain	 global	
cognitive	decline	per	year.	Significant	global	cognitive	decline	(yes/no)	was	defined	as	
belonging	to	the	5%	of	participants	with	the	highest	cognitive	decline	(delta	g-factor)	




The	 performance	 of	 DSI	 in	 predicting	 occurrence	 of	 global	 cognitive	 decline	 was	
evaluated	using	cross-validation.	The	area	under	 the	 receiver-operator	curve	 (AUC)	





The	 confidence	 interval	was	determined	with	 the	 corrected	 resampled	 t-test	 for	CV	
estimators	of	the	generalization	error.35	AUCs	were	considered	significantly	different	if	
the	95%	confidence	interval	of	their	difference	did	not	contain	zero.























feature selection on MrI features
In	this	study,	hundreds	of	MRI	features	were	extracted	from	images.	It	is	likely	that	
many	of	those	features	are	not	very	efficient	in	detecting	cognitive	decline.	Typically	









drop	out,	despite	 their	high	relevance.	To	prevent	entire	 top-level	 feature	categories	
to	drop	out	of	 the	model,	we	chose	 to	only	apply	feature	selection	on	 the	MRI	fea-



































to	without	age	correction,	with	an	AUC	of	0.55	 (0.50	 -	0.61).	For	 the	other	 feature	








Rnac Rnac Rac(N=127) N=2415)
Age,	years 0.38 - 71.2	(10.1) 60.3	(8.7)
Sex,	female 0.01 - 73	(54.5%) 1340	(55.6%)
Objective	cognitive	test	results 0.28 0.16 - -
Word	Learning	Test	immediate	recall 0.09 0.02 7.7	(2.2) 8.1	(2.0)
Word	Learning	Test	delayed	recall 0.05 0.04 7.9	(2.9) 8.2	(2.8)
Reading	subtask	of	Stroop	test,	s 0.20 0.03 17.2	(2.7) 16.3	(2.9)
Color	naming	subtask	of	Stroop	test,	s 0.18 0.06 23.6	(3.6) 22.3	(4.0)
Interference	subtask	of	Stroop	test,	s 0.32 0.10 53.8	(20.3) 44.0	(13.0)
Letter-Digit	Substitution	Task,	number	of	
correct	digits
0.15 0.00 29.7	(6.7) 32.2	(6.2)
Word	Fluency	Test,	number	of	animals 0.04 0.08 23.2	(5.7) 23.8	(5.7)
Purdue	Pegboard	test,	number	of	pins	placed 0.15 0.07 10.3	(2.1) 10.9	(1.7)
Mini-mental-state	examination 0.14 0.11 27.8	(1.7) 28.4	(1.5)
Education1 0.07 0.07 3	(1-3) 3	(2-5)
Cardiovascular	risk	factors 0.34 0.27 - -
Alcohol1,	glasses	per	week 0.06 0.04 3.5	(0.3-5.5) 5.5	(1.0-5.5)
Systolic	blood	pressure,	mmHg 0.24 0.04 146.2	(20.3) 135.9	(19.6)
Diastolic	blood	pressure,	mmHg 0.00 0.02 82.8	(9.4) 82.4	(10.6)
Blood	pressure	lowering	medication 0.26 - 51	(38.3%) 284	(11.9%)
Body	Mass	Index,	kg/m2 0.07 0.07 28.2	(4.4) 27.4	(4.1)
Serum	cholesterol,	mmol/L 0.11 0.12 5.4	(0.9) 5.6	(1.1)
HDL-cholesterol,	mmol/L 0.04 0.09 1.4	(0.4) 1.5	(0.4)
Lipid	lowering	medication 0.13 - 46	(34.6%) 510	(21.3%)
Smoking 0.08 0.08 - -
Never - - 49	(36.6%) 746	(31.2%)
Former - - 54	(40.3%) 1154	(48.2%)
Current - - 31	(23.1%) 492	(20.6%)
Diabetes	mellitus,	presence 0.09 - 24	(18.2%) 220	(9.2%)
APOE-E4	allele	carriership 0.02 - 39	(30.2%) 639	(28.3%)
MRI	features 0.41 0.25 - -
Intra-cranial	volume,	mL 0.03 0.00 1137	(119) 1144	(113)
Brain	tissue	volume 0.38 0.08 - -
White	matter	volume,	mL 0.13 0.01 390	(60) 419	(57)
Gray	matter	volume,	mL 0.10 0.01 522	(54) 537	(52)
CSF	volume,	mL 0.29 0.07 223	(53) 186	(46)
Brain	region	volume 0.35 0.12 - -
Hippocampus	volume,	mL 0.23 0.09 6.4	(0.8) 6.8	(0.7)
White	matter	lesion	volume1,	mL 0.31 0.08 4.5	(2.5-9.4) 2.4	(1.4-4.3)
Cerebral	microbleeds,	presence 0.09 - 33	(24.6%) 370	(15.6%)
Lacunar	infarcts,	presence 0.04 - 10	(7.5%) 72	(3.0%)
































Rnac Rnac Rac(N=127) N=2415)
Global	MD,10−3 mm2/s 0.33 0.07 0.8	(0.03) 0.7	(0.03)
Global	cortical	thickness,	mm 0.08 0.01 2.4	(0.2) 2.5	(0.1)












figure 2A.	Mean	AUC	 for	 several	 combinations	 of	 features	without	 correcting	




















































features	for	age. figure 4B is	with	the	non-binary	features	corrected	for	age.	








figure 4B	is	with	the	non-binary	features	corrected	for	age.	Features	with	R < t	were	excluded.
dISCuSSIoN
The	 objective	 of	 this	 study	 was	 to	 assess	 whether	 global	 cognitive	 decline	 can	 be	
predicted	using	multi-variate	 data	with	 the	 previously	 proposed	DSI.	We	 found	 the	
best	 prediction	 performance,	 evaluated	with	AUC,	 using	 only	 age	 as	 input	 feature.	





performances	 of	 DSI	 for	 prediction	 of	 dementia7	 in	 the	 population-based	 CAIDE	
study,	consisting	of	2000	participants	who	were	randomly	selected	from	four	separate,	
population-based	samples,	originally	studied	in	midlife	(1972,	1977,	1982,	or	1987),38 









DSI,	 however,	 performed	worse	when	using	only	MRI	 features,	 compared	 to	 using	
only	age.	We	speculate	that	the	high	relevance	of	the	MRI	features	may	be	explained	
by	age-specific	effects	that	are	captured	in	these	MRI	features,	which	is	supported	by	




decline	 could	 be	 present	 in	 the	 other	 features.	 In	 this	 study,	 however,	 they	 did	 not	
improve	 the	 predicting	 performance	when	 added	 to	 age.	To	 our	 surprise	we	 found	
that	APOE-4	allele	carrier-ship	had	a	low	relevance	weight	and	did	not	improve	the	
performance	 of	 DSI,	 even	 though	 it	 is	 the	 best	 known	 genetic	 risk	 factor	 for	AD.	
This	is	in	contrast	to	a	previous	study	focusing	on	the	progression	from	MCI	to	AD,	
which	found	APOE-genotype	to	have	high	predictive	value.41	It	may	be	that	our	study	
population	was	 too	 young	 to	 show	 effect	 of	APOE	 on	 prediction	 (mean	 age	 60.9),	
since	 the	 risk	progression	effect	of	APOE-4	allele	carriership	has	been	described	 to	
peak	 between	 ages	 70	 and	75	 years.42	The	 relevance-based	 feature	 selection	 on	 the	
MRI	features	showed	an	increase	in	the	AUC,	but	only	when	the	nonbinary	features	







of	0.70	was	obtained,	 showing	 the	potential	of	 the	other	 features.	One	 limitation	of	
261
Predicting	global	cognitive	decline	in	the	general	population	using	the	Disease	State	Index





chine	 learning	DSI	 tool	 for	 prediction	of	 global	 cognitive	decline.	Strengths	of	 our	




towards	 relatively	healthy	subjects.	Also,	mortality	and	drop-out	was	not	 taken	 into	
account.	 Persons	who	 are	 lost	 to	 follow-up	usually	 have	 a	 poorer	 health	 status	 and	
are	therefore	more	likely	to	develop	cognitive	decline	or	die	before	onset	of	cognitive	
decline.	The	exclusion	of	these	ssumingly	more	severe	cases	might	have	lowered	the	












Conclusion and future work
Based	 on	 our	 results	we	 can	 conclude	 that	 age	 is	 the	most	 important	 predictor	 for	
cognitive	decline	in	the	general	population	using	DSI.	Other	features	showed	having	
potential,	 but	 did	 not	 improve	 prediction	 performance.	A	 next	 step	 could	 be	 to	 use	
longitudinal	 features	 in	DSI,	as	 these	might	 improve	 its	prediction	performance.	To	
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MAIN fINdINGS ANd INterPretAtIoN
General discussion
The	main	objectives	of	my	thesis	were	to	study	determinants	of	white	matter	micro-
structural	 changes	 as	 assessed	 with	 Diffusion-Tensor-Imaging	 (DTI),	 and	 to	 study	
the	role	of	white	matter	microstructural	changes	in	age	related	brain	diseases	such	as	
cognitive	decline,	dementia,	and	neurovascular	disease.
In	 this	 chapter,	 I	 will	 first	 discuss	 my	 main	 findings	 and	 I	 will	 consider	 possible	
pathways	 underlying	 the	 found	 associations	 and	 additionally	 some	 methodological	
considerations.	Next,	 I	will	 discuss	 the	 implications	 of	 the	 findings	with	 respect	 to	
clinical	practice	and	finally	I	will	discuss	future	perspectives.
Main findings
determinants of white matter microstructural integrity
Chapter 2	 in	 this	 thesis	describes	 the	different	determinants	of	white	matter	micro-













microstructural	 integrity.	 Reduced	 lung	 function	 was	 linked	 to	 lower	 white	 matter	
microstructural	 integrity	 in	 particular	 in	 the	 association	 tracts.	 In	 the	 last	 chapter	 I	











First,	 a	 vascular	 etiologic	 pathway	 has	 often	 been	 hypothesized.1	 Vascular	 brain	
pathology	 may	 lead	 to	 a	 reduction	 in	 white	 matter	 perfusion,	 for	 example	 due	 to	
impaired	 autoregulation,	 resulting	 in	 white	 matter	 damage.2-5	 Another	 mechanism	
may	 be	 that	 the	 presence	 of	 vascular	 factors,	 not	 causing	 direct	 damage,	 interact	




sels	 for	 example	 in	 the	 kidney	 or	 retina	 and	 brain	 are	 similar	with	 anatomical	 and	
hemodynamic	 similarities.7	My	 findings	 in	 chapter 2.2	 indeed	 confirmed	 a	 role	 of	
vascular	factors.	The	association	between	kidney	function	and	cerebral	white	matter	
microstructure	 attenuated	 after	 adjusting	 for	 cardiovascular	 risk	 factors,	 indicating	
that	the	association	was	partly	driven	by	cardiovascular	factors.	Furthermore,	I	found	








fects	of	vascular	 factors	or	 subclinical	vascular	 factors	or	a	genetic	predisposition).	




in	elderly.	Oxidative	stress	has	also	been	proposed	as	one	of	 the	possible	 factors	 in	
the	pathophysiology	of	age-related	diseases	such	as	dementia.9,10	Alternatively,	direct	
toxic	 influences	on	 the	brain	 for	example	due	 to	high	 thyroid	hormone	 levels	could	
underlie	 some	 of	 the	 found	 associations.	Hypoxia,	 resulting	 in	metabolic	 decreases	












associations.	More	 in-depth	measurements	 of	 cerebral	 perfusion	 and	 autoregulation	




white matter microstructural integrity and cognitive decline, mild cognitive 












support	 the	 hypothesis	 that	 white	matter	 microstructural	 integrity	 is	 an	 earlier	 and	
potentially	more	sensitive	marker	of	white	matter	damage.
what underlies these associations?
The	role	of	vascular	factors	in	the	association	of	white	matter	microstructural	integrity	
and	 age-related	 brain	 diseases	 seems	 evident.	 Indeed,	 in	 chapter 3.1,	 I	 found	 that	
cardiovascular	 risk	 factors	were	 related	 to	mild	cognitive	 impairment,	a	 transitional	
stage	between	aging	and	dementia.	Besides	cardiovascular	risk	factors,	also	markers	
of	 small	 vessel	 disease	 such	 as	white	matter	 hyperintensities	were	 related	 to	MCI,	









of	 the	 found	associations	did	not	attenuate	after	adjustments	 for	cardiovascular	 risk	
factors,	as	we	described	in	chapter 3.2 and 3.3	in	which	we	focused	on	tract-specifi	c	
white	matter	microstructural	integrity	and	the	association	with	cognition	and	dementia.	
Also,	adjusting	for	cardiovascular	risk	factors	did	not	change	the	estimates	substan-





Cognitive	 performance	 consists	 of	 developmental	 and	 degenerative	 components.16 












These	 white	 matter	 tracts	 have	 been	 associated	 with	 cognitive	 performance	 previ-
ously.17	This	study	suggests	that	the	studied	genetic	variants	associated	with	cognition	
represent	both	developmental	and	degenerative	components	of	cognitive	performance.	
This	indicates	that	the	results	in	chapter 3.2 and 3.3	assessing	the	relation	of	white	
matter	microstructural	integrity	and	cognition	and	dementia,	apart	from	neurodegen-
eration	can	also	be	partly	explained	by	developmental	infl	uences.
To	 investigate	 the	 potential	 clinical	 use	 of	 advanced	 imaging	markers	we	 aimed	 to	




(DSI)18,	 to	 predict	 cognitive	 decline	 using	 (advanced)	 imaging	 and	 non-imaging	
features,	including	global	and	tract-specific	DTI	-measures.	Though	for	several	of	the	
brain	imaging	markers	that	were	introduced	in	the	DSI,	independent	associations	with	












Methodological considerations related to studies in this thesis
Population-based study design
The	 studies	 discussed	 in	 this	 thesis	were	 conducted	within	 the	Rotterdam	 Study,	 a	






























our	 results,	 since	white	matter	microstructural	 changes	may	be	 intermediates	 in	 the	
relation	 between	 vascular	 factors	 and	 different	 outcomes	 such	 as	 dementia.	 I	 pres-
ent	a	basic	model	and	additionally	a	model	including	vascular	factors	in	most	of	the	




However,	chapter 3.3	 is	 a	 longitudinal	 study	 on	 the	 relation	 between	white	matter	
microstructural	 integrity	 and	 dementia	 and	 cognitive	 decline.	 To	 address	 potential	






From	 2005	 onwards,	MRI	was	 implemented	 in	 the	 study	 protocol	 and	 a	 dedicated	
research	scanner,	undergoing	a	QA	protocol	keeping	the	system	unchanged	(no	major	





protocol	was	designed,	 the	number	of	gradient	directions	was	chosen	 to	best	fit	 the	


































thesis,	but	 also	on	 the	 fact	 that	white	matter	microstructural	 changes	precede	white	







fibres.36	 Interpretation	 of	DTI-measures	 therefore	must	 be	 done	with	 caution.	Until	
















association	 tracts	were	 related	 to	 different	 outcomes.	For	 example	 the	white	matter	




be	 detected	 using	 tract-specific	 analyses,	 with	 interesting	 possibilities	 towards	 risk	
stratification	and	early	disease	prevention.




Clinical implications and future research
In	 this	 thesis	 I	 contributed	 to	 the	 establishment	 of	 reference	 values	 of	 change	 in	
DTI-measures	 in	 aging.	 Furthermore,	 I	 highlight	 the	 added	 value	 of	 (tract-specific)	
DTI-measures	over	 conventional	MRI	markers	 to	 study	determinants	 and	outcomes	
of	 white	 matter	 disease.	 This	 further	 supports	 the	 observation	 that	 macrostructural	
markers	only	represent	the	tip	of	the	iceberg	of	the	white	matter	damage.	More	etio-
logical	 knowledge	 can	 be	 obtained	 using	 (tract-specific)	DTI.	 I	 found	 tract-specific	
differences;	among	the	15	white	matter	tracts,	the	association	tracts	most	often	related	
to	 age-related	 brain	 outcomes	 such	 as	 cognitive	 performance.	This	may	have	 clini-













the	mediator	 in	 regression	 analysis.	However,	 recently	 alternative	 analytic	methods	
have	 been	 introduced	 to	 improve	 the	 interpretation	 of	mediation	 analyses.41	 Future	
research	 should	 incorporate	 these	methods	 to	 investigate	whether	 changes	 in	white	
matter	microstructural	integrity	actual	mediate	the	association	of	several	determinants	
with	age-related	outcomes.
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As	 our	 life	 expectancy	 rises,	 the	 prevalence	 of	 common	 age-related	 brain	 diseases	




conventional	MRI,	constitute	only	 the	 tip	of	 the	 iceberg	of	 the	white	matter	pathol-
ogy	that	have	occurred.	Recently,	it	has	become	possible	to	investigate	white	matter	













ence	 values	 of	 change	 in	 diffusion-weighted	MRI	measures	 in	 aging	we	performed	
a	 longitudinal	 analysis	 in	chapter 2.1.	 I	 found	 loss	of	white	matter	microstructural	
integrity	widespread	 in	 the	brain.	Global	 fractional	 anisotropy	 (FA)	decreased,	MD	
increased	after	2	years	of	follow-up.	The	small	vessels	in	kidney	and	retina	are	simi-
lar	with	anatomical	and	hemodynamic	 similarities.	 In	chapter 2.2 and chapter 2.3 





suggests	 that	white	matter	microvascular	 damage	 is	more	widespread	 than	 visually	
detectable	as	white	matter	hyperintensities.	In	chapter 2.4	focusing	on	lung	function	
and	 white	 matter	 microstructure	 we	 found	 tract-specific	 differences.	 Reduced	 lung	






an	age-dependent	effect	of	 free	 thyroxine	(FT4).	Higher	FT4	 levels	were	associated	
with	larger	brain	volumes	and	higher	white	matter	microstructural	integrity	in	younger	




integrity	 and	 age-related	 brain	 diseases.	Higher	 age,	 stroke	 and	 cardiovascular	 risk	
factors	were	related	to	mild	cognitive	impairment	(MCI)	in	chapter 3.1.	In	addition,	
persons	with	MCI,	in	particular	amnestic	MCI	had	larger	white	matter	hyperintensity	

























both	 the	 developmental	 and	 degenerative	 components	 of	 cognitive	 performance.	 In	







prediction.	This	calls	 for	other	prediction	 tools,	more	advanced	 imaging	markers	or	
other	analytical	approaches	in	the	prediction	of	age-related	diseases.
Finally	 in	chapter 4	 I	discuss	 the	main	findings	of	 this	 thesis,	methodological	con-
siderations,	 clinical	 implications,	 and	 I	make	 recommendations	 for	 future	 research.	
My	 conclusions	were	firstly	 that	 systemic	 influences	 relate	 to	 a	 lower	white	matter	












De	 levensverwachting	van	mensen	neemt	 toe	en	als	 een	gevolg	daarvan	zullen	ook	
vaak	voorkomende	aan	veroudering-gerelateerde	hersenziekten	zoals	cognitieve	ach-
teruitgang,	 dementie	 en	 vasculaire	 hersenziekten	 gaan	 toenemen.	 Er	 is	 nog	 relatief	
weinig	 bekend	 over	 de	 oorzaken	 van	 aan	 veroudering-gerelateerde	 ziekten	 en	 ook	
preventieve	en	curatieve	interventies	zijn	schaars.	Dat	de	witte	stof	van	de	hersenen	








corticale	 gebieden	 in	 de	 hersenen	 minder	 goed	 met	 elkaar	 kunnen	 communiceren,	
resulterend	in	disconnectiviteit	wat	uiteindelijk	kan	leiden	tot	cognitieve	klachten	en	
andere	 aan	 veroudering-gerelateerde	 hersenziekten.	 Bevolkingsstudies	 in	 personen	
van	middelbare	en	oudere	leeftijd	die	deze	microstructurele	veranderingen	van	de	witte	
stof	globaal,	maar	ook	in	specifieke	witte	stof	banen	hebben	bestudeerd	zijn	schaars.
Het	 doel	 van	 het	 onderzoek	 beschreven	 in	 dit	 proefschrift	was	 om	met	 behulp	 van	
diffusie-gewogen	MRI	verschillende	factoren	van	microstructurele	witte	stof	verande-
ringen	te	onderzoeken	en	de	relatie	van	deze	microstructurele	witte	stof	veranderingen	










De	kleinste	bloedvaten	 in	de	nier,	 retina	en	de	hersenen	 tonen	veel	 anatomische	en	










uitgebreider	 zijn	 dan	wordt	 gezien	 als	witte	 stof	 hyperintensiteit.	 In	hoofdstuk 2.4 
onderzocht	 ik	 de	 relatie	 tussen	 longfunctie	 en	witte	 stof	microstructurele	 integriteit	
en	 vond	 ik	 verschillen	 tussen	witte	 stof	 banen.	Verminderde	 longfunctie	 relateerde	
aan	een	verminderde	witte	stof	microstructurele	integriteit,	en	dan	met	name	van	de	
associatie	 vezels.	 Dit	 zou	mogelijk	 verklaard	 kunnen	worden	 door	 de	 anatomische	
locatie	van	de	associatie	vezels	in	waterscheidingsgebieden,	waardoor	deze	witte	stof	
vezels	mogelijk	meer	 gevoelig	 zijn	 voor	 vasculaire	 schade.	 In	hoofdstuk 2.5	 vond	

















tuur	 in	 vrijwel	 het	 gehele	 brein	 maar	 ook	 met	 name	 in	 de	 associatie,	 projectie	 en	


















dementie,	 parkinsonisme,	 beroerte	 en	MRI	 markers	 van	 het	 brein.	 De	 bestudeerde	
genetische	 varianten	 hingen	 samen	 met	 cognitieve	 achteruitgang,	 een	 groter	 brein	
volume	en	een	betere	educatie.	Dit	suggereert	dat	deze	genetische	varianten	zowel	de	
ontwikkelingscomponent	als	de	degeneratieve	component	van	cognitie	representeren.	






spellen	 aan	de	 hand	van	verschillende	markers	 inclusief	MRI	markers.	 Ik	 vond	dat	
leeftijd	 de	 belangrijkste	 predictor	 was	 en	 dat	 andere	 predictors	 geen	 toegevoegde	





sche	 limitaties	en	de	klinische	 implicaties	van	dit	proefschrift	 en	geef	 ik	 suggesties	
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skills,	 intellect	 en	 perfectionisme	 zijn	 bewonderenswaardig.	Daarnaast	 ben	 je	 altijd	
bereikbaar,	meedenkend	en	ontzettend	lief.	Bedankt	daarvoor	en	voor	alle	begeleiding	
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